Laser combination with in vivo target feedback analysis

A multi-wavelength laser system with real-time control adjusts to changing tissue characteristics, addressing inefficiencies in laser ablation by optimizing tissue removal and visibility, thus improving procedural efficiency and accuracy.

JP2024163193AInactive Publication Date: 2024-11-21GYRUS ACMI INC
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
JP2024150787
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2021-10-22
Filing Date
2024-09-02
Publication Date
2024-11-21
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

Existing laser-based intracorporeal procedures face inefficiencies due to changes in tissue composition during ablation, such as transitioning from highly vascularized to less vascularized tissue, leading to prolonged procedures and potential tissue obscuration from excessive light absorption, which affects the accuracy of target site location.

Method used

A system with multiple laser modules of varying wavelengths, controlled by a feedback analyzer and controller, adjusts laser activation based on real-time tissue characteristics, such as vascularity, to optimize ablation efficiency and visibility.

Benefits of technology

The system ensures efficient and precise tissue removal by adapting to changing tissue properties, reducing procedure duration and minimizing tissue obscuration, thereby enhancing procedural accuracy and safety.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024163193000001_ABST
    Figure 2024163193000001_ABST
Patent Text Reader

Abstract

To provide an approach making it possible to identify characteristics of an in vivo target being ablated and removed, before or during a procedure, in real time, and control an ablation device according to the identified characteristics.SOLUTION: A laser can be controlled based on different tissue compositions, e.g., in real time. After a first time period, a first composition of an in vivo target site can be identified. Based on the first composition, a plurality of lasers can be controlled to emit light of a first wavelength, where the controlling includes activating a first combination of the plurality of lasers. After a second time period, a second composition of the in vivo target site different from the first composition can be identified. Based on the second composition, a plurality of lasers can be controlled to emit light of a second wavelength, which can include, e.g., activating a second combination of the plurality of lasers. The first combination of the plurality of lasers can be different from the second combination of the plurality of lasers.SELECTED DRAWING: Figure 15
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] CROSS-REFERENCE TO RELATED APPLICATIONS This application claims the benefit of priority to U.S. Provisional Patent Application No. 63 / 270,730, filed October 22, 2021, the contents of which are incorporated herein in their entirety.

[0002] This document relates generally, but not exclusively, to an intracorporeal device that can be used in various intracorporeal procedures. More specifically, but not exclusively, this application relates to a device that can use a light source to ablate an intracorporeal target, and can include adjusting the light source during the procedure based on one or more characteristics of the target. [Background technology]

[0003] A variety of internal procedures involve laser surgery. For example, laser surgery may be used to remove kidney stones during laser lithotripsy procedures, remove cancerous tissue, make incisions in tissue, vaporize tissue, such as during the treatment of Benign Prostatic Hyperplasia (BPH), etc. However, a number of problems can arise when lasers are used to perform internal procedures.

[0004] For example, during a procedure for removing tissue at an internal target site, the composition of the tissue may change when the tissue at the internal target site is removed. For example, the tissue may be highly vascularized. However, the parameters for the laser used during removal may be set to effectively remove the highly vascularized tissue. However, during the procedure, when the highly vascularized tissue is removed, the practitioner may also encounter less vascularized tissue. Nevertheless, the parameters for the laser are set to remove the highly vascularized tissue instead of the less highly vascularized tissue. Thus, the efficiency of tissue removal may decrease, which may prolong the procedure for removing tissue from the internal target site.

[0005] Once the practitioner realizes that the tissue composition has changed, i.e., from highly vascularized to less vascularized, the practitioner must adjust the laser parameters to improve the efficiency of removing the less vascularized tissue. Furthermore, the process may repeat itself when the practitioner may be faced with highly vascularized tissue after the less vascularized tissue has been removed, thereby creating the same problems discussed above.

[0006] Furthermore, in some instances, the wavelengths of light emitted by the laser system during tissue removal procedures may be highly absorbed, whereby charring of the tissue at the internal target site may occur, causing the tissue to become obscured by smoke or opaque, thereby preventing the practitioner removing the tissue from accurately viewing the internal target site. Thus, the practitioner may not be able to tell whether the laser energy is penetrating too much (or not enough) into the internal target site. Summary of the Invention [Problem to be solved by the invention]

[0007] Thus, there is a need for a technique that is capable of (i) identifying, in real time, prior to or during the procedure, one or more characteristics of an internal target to be ablated and removed, and (ii) controlling an ablation device in accordance with the one or more identified characteristics. [Means for solving the problem]

[0008] A system for performing a medical procedure at an internal target site (e.g., ablation of a target) is described. The system can have multiple laser modules with optical emissions of various wavelengths. A controller can control activation and / or deactivation of individual laser modules of the laser modules based on one or more characteristics of the target, etc. For example, in response to laser illumination of the target site, a fluorescent signal, a reflected signal, an absorption signal, a scattering signal, or other response optical signal from the target site in response to illumination of the target site can be used to determine a characteristic of the target site. A feedback analyzer can be used to determine a spectrum of the emitted fluorescent signal, reflected signal, or other response signal. Based on the analysis, the system can determine one or more characteristics of the target (such as type, size, shape, depth, composition, composition profile, etc.). The determined characteristics can be used to control one or more laser modules of the system. For the sake of brevity, this document focuses on a specific example that highlights a scenario in which the response signal is a fluorescent response signal, but in addition or alternatively, one or more other illumination response signals can be used as well.

[0009] For example, one or more laser modules may be activated and / or deactivated in real time. As discussed herein, the laser module may have a laser source, which is then controlled. A feedback analyzer may determine changes in one or more characteristics of the target occurring during the medical procedure, and a controller may selectively activate and / or deactivate one or more laser modules in real time in response to the determined changes in the characteristics of the target. By way of example, one or more laser modules may be controlled based on the depth of the target site. Depth may refer to the distance from the surface of the patient's body to the target site, or the amount of material removed, and the like. Furthermore, target depth may refer to the type of tissue to be removed or the type of tissue to be analyzed. When the target site is at a first depth, one or more laser modules may be controlled to operate in a first configuration, such as by using pre-stored control information corresponding to the first depth. By way of further example, the system may have three laser modules, and in the first configuration, a first laser module may be activated, whereas the remaining two laser modules are deactivated. When the target is ablated to a second depth different from the first depth, the system may be switched to operate in a second configuration using pre-stored control information corresponding to the second depth for the purpose of deactivating the first laser module and activating the second and third laser modules.

[0010] Each laser module of the multiple laser modules may emit light of different wavelengths, which may have different penetration depths within the body and / or may remove different types of targeted material at different rates. Thus, by selectively activating and / or deactivating the laser modules based on one or more determined characteristics of the target at the internal body site, the therapeutic effect of the target at the internal body site may be tailored or optimized.

[0011] When multiple laser modules are selected, the light emitted from the selectively activated laser modules is directed to a laser light combiner, which combines the light from the output of each activated laser module. This combined light output can be directed (e.g., via an optical path) to ablate the internal target. Thus, the controller can control which of the laser modules should be activated to emit light based on determined characteristics of tissue at the internal target site, which may be acquired before and / or during the medical procedure. At a first time t1, the controller can activate a first combination of laser modules to emit light based on previously acquired or real-time characteristics of the target at the internal target site. At a later second time t2, the controller can activate a different second combination of laser modules to emit light based on changes in the characteristics of the target at the determined internal target site at the second time. [Brief description of the drawings]

[0012] [Figure 1] 1 illustrates an example of a portion of a system that may include an endoscope for use in a procedure to remove material from a target site. [Diagram 2] 2A-2C show examples of various features of the endoscope of FIG. 1. [Diagram 3] FIG. 2 illustrates an embodiment of a portion of a feedback analyzer of the system of FIG. 1. [Figure 4] FIG. 1 illustrates an example of a portion of a method for determining a characteristic of a target site. [Diagram 5] FIG. 13 illustrates an example of illuminating a target site, such as with pulsed light. [Figure 6] FIG. 1 shows an example of the fluorescence response emission of a fluorophore excited by illumination light. [Figure 7] FIG. 1 shows an example of emission and sensing of a fluorescent response signal from a target site. [Figure 8]5A-5C show examples of removing tissue from a target site using a laser beam from a laser having one or more parameters established or adjusted based on the method shown in FIG. [Figure 9] FIG. 1 shows an example of the difference in fluorescence response intensity as a function of wavelength for tumorous or healthy tissue. [Figure 10] FIG. 1 illustrates an example of determining a characteristic of a target site. [Figure 11] FIG. 1 illustrates an example of illuminating a target site with pulsed light. [Figure 12] FIG. 13 shows an example of illumination and sensing of a fluorescent response signal from a target site. [Figure 13A] FIG. 2 illustrates components of an imaging platform in the system of FIG. 1. [Figure 13B] FIG. 2 illustrates components of an imaging platform in the system of FIG. 1. [Figure 14] FIG. 2 illustrates a laser combiner of the imaging platform in the system of FIG. 1. [Figure 15] FIG. 1 illustrates a method for controlling in real time a system for removing tissue from an internal target site. [Figure 16] 1A-1C show an example of tissue removal from an internal target site using a laser beam. [Figure 17] FIG. 1 illustrates illumination of an internal target site with pulsed light. [Figure 18] FIG. 1 illustrates the emission and sensing of fluorescent signals from an internal target site. [Figure 19] FIG. 1 illustrates a method of controlling a system for the removal of tissue from an internal target site. [Figure 20] FIG. 1 is a schematic diagram illustrating a computer-based clinical policy support system configured to determine tissue composition in an internal target. [Figure 21] FIG. 2 is a block diagram illustrating an embodiment of a software architecture that may be installed on a machine. [Figure 22] FIG. 1 is a schematic diagram illustrating a machine in the form of a computer system within which a set of instructions may be executed to cause the machine to perform any one or more of the methodologies discussed herein. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0013] This document describes a method of controlling a system for removing tissue, which may include kidney stones, from an internal target site in real time. The system may have a feedback analyzer operatively connected to a laser controller that controls a plurality of laser modules. The feedback analyzer may determine the composition of the tissue during tissue removal from the internal target site. Based on the composition of the tissue at the internal target site, the feedback analyzer may provide feedback to the laser controller, which may be used to control each laser module of the plurality of laser modules. When the composition of the tissue at the internal target site changes, the feedback analyzer may monitor and determine this composition change in real time, i.e., provide this composition change as feedback to the laser controller as the change occurs. The laser controller may control each laser module of the plurality of laser modules in real time based on the composition of the tissue at the internal target site.

[0014] Each laser module of the multiple laser modules can emit light of various wavelengths. These various wavelengths can target various characteristics (e.g., type, size, shape, depth, composition, composition profile, etc.) of tissue to be ablated, at various rates, etc. The multiple laser modules can be operatively connected to a laser light combiner that can combine the output from each laser module of the multiple laser modules. The laser light combiner can provide the combined laser light output to the internal target site, such as via an optical path. The output from the combiner can be used to ablate tissue from the internal target site. Thus, a laser controller can control which laser module of the multiple laser modules should emit light based on the composition of tissue at the internal target site. At a first time t1, the laser controller can control a first combination of laser modules to emit light based on the composition of tissue, e.g., at the internal target site, as determined by the feedback analyzer, at the first time. At a second time t2, the laser control device can control a different second combination of laser modules, different from the first combination of laser modules, to emit light based on the tissue composition at the internal target site at the second time determined by the feedback analyzer.

[0015] FIG. 1 illustrates an example of a portion of a system 100 that may be used to treat or remove material from a target site, such as an internal body site. The system 100 may include an endoscope 102 in communication with a platform 104 that may be used to provide an image of the target site to a practitioner, such as a medical professional. For example, the endoscope 102 may include a nephroscope, cystoscope, ureteroscope, or any other type of endoscope. The endoscope 102 may have a body 106 that is at least partially insertable into a patient. The body 106 may have a handle, hub, or other graspable proximal portion 108, an elongated rigid portion 110 extending from the graspable proximal portion 108, and a flexible distal portion 112 extending distally from the elongated rigid portion 110 to a distal end 114. An articulated control 116 may be located on the graspable proximal portion 108. An articulated control 116 can be actuable by the practitioner as the practitioner grasps the graspable proximal portion 108. The articulated control 116 can adjust the position of the flexible distal portion 112. The graspable proximal portion 108 can further have an electrical port 118 (e.g., via one or more wires extending along the body 106) that can be coupled to a substrate 200 (FIG. 2) that can be located at the distal end 114 of the body 106. Although the examples described herein include endoscopes, the present subject matter is not limited to only endoscopes or devices that perform spectroscopic techniques, but can also include the use of other types of therapeutic devices.

[0016] The endoscope 102 can have a visualization system at the distal end 114 of the body 106 to enable the practitioner to visualize the target site. The visualization system can illuminate a working area of ​​material, such as tissue or a stone (e.g., a kidney stone or a pancreaticobiliary or gallbladder stone), and can generate a video image or one or more still images of the illuminated area of ​​material. The visualization system can transmit the video image to a display device 120.

[0017] The visualization system may have at least one light source 202 located on a substrate 200 at the distal end 114 of the endoscope 102, as shown in FIG. 2. Alternatively, the light source may be located at the proximal end of the endoscope 102 (or may be located remotely from the endoscope 102) and transmit light to the distal end of the endoscope via, for example, optical fibers or illumination channels. The substrate 200 may include one or more of a circuit board, a hybrid chip, a ceramic component, and other suitable components or elements. An electrical port 118 may receive electrical power to power the circuit board on the substrate 200. The circuit board or other substrate 200 may wirelessly communicate digital video signals to the display device 120. The circuit board or other substrate 200 may mechanically support and electrically power the light source 202. In addition to the circuit board or other substrate 200 and the light source 202 located at the distal end 114 of the endoscope 102, an imaging sensor 302 may also be located at the distal end 114 of the endoscope 102. For example, the imaging sensor 302 may include an imaging camera, such as a CCD camera or CMOS camera that is sensitive to ultraviolet (UV), visible (VIS), or infrared (IR) wavelengths.

[0018] A circuit board or other substrate 200 may alternatively be located in the proximal portion 126 of the endoscope 102, in the graspable proximal portion 108 of the endoscope 102, or the like, along with a light source 202. The substrate 200 may have the components and functionality described herein when located in either the distal portion 114 or the proximal portion 126 of the endoscope 102.

[0019] The light source 202 may include, among others, a light emitting diode (LED) or a xenon light. The light source 202 may include an LED. The LED may output white light, which may include one or more of blue, green, yellow, and red wavelengths. The light source 202 may include an LED that may emit light of various wavelengths, such as to aid in obtaining one or more target characteristics at a target site, as described further below. In some embodiments, the light source 202 may function as a user-visible aiming light for the endoscope 102, which the practitioner may visually observe and use the standard light to determine where to point the laser of the endoscope 102, while simultaneously using the standard light to illuminate the target site to detect one or more fluorescent or other response signals from the target site, as described later herein.

[0020] The light source 202 can emit light directed distally away from the distal end 114 of the body 106, such as to illuminate material at the target site. As described above, the light source can be an external light source (e.g., external to the endoscope 102) that provides light transmitted through the body 106 of the endoscope 102, such as through an optical fiber or fiber optic bundle, to illuminate material at the target site. The light source 202 can emit white light to illuminate the stone. The white light can allow the practitioner to observe a discoloration or other color-based effect on the material at the target site at or near the distal end 114 of the body 106. The light source 202 can additionally or alternatively emit blue light to illuminate material at the target site. Blue light can be well suited to indicate thermal diffusion, and can thereby be used to detect actual or potential thermal damage in the material. Other color wavelengths or color bands may be used, such as red, amber, yellow, or green. The light source 202 may be coupled to an optical lens 206, which may refractively or otherwise angularly adjust the light output from the light source 202. The optical lens 206 may narrow the beam of light output from the light source 202. Additionally, the optical lens 206 may widen the beam of light output from the light source 202. Such angular adjustments may help ensure that material at the target site is adequately illuminated within a specified angular field of view.

[0021] The optical fiber 204 or fiber optic bundle may be integrated into the endoscope 102. The optical fiber 204 may extend along a fiber channel (which may be the working channel or may be a channel different from the working channel) within the body 106 of the endoscope 102. The optical fiber 204 may be separate from the endoscope 102. The optical fiber 204 may be fed along a fiber channel of the endoscope 102 before or during use and retrieved from the fiber channel of the endoscope 102 after use. The optical fiber 204 may be coupled, such as via a suitable connector, to a material removal device 501 (FIG. 5) external to the endoscope 102, such as a laser emitter, which may deliver a laser beam to material at a target site for material removal. The target site may include a kidney stone that may be ablated by the laser beam into a fragmented stone fragment. The target site may include tissue that may be ablated from the target site by the laser beam. The material removal device 501 is not limited to only a laser beam. For example, an ultrasound transducer may be used to ablate soft and / or hard tissue from a target site.

[0022] The laser beam generated by the laser emitter of the material removal device 501 can have a wavelength corresponding to the spectral peak of absorption of human blood or saline water, such as 2100 nm, 1942 nm, and other wavelengths. For example, a wavelength in the range between 1900 nm and 3000 nm can correspond to the spectral region of light absorption of water, whereas a wavelength between 400 nm and 520 nm can correspond to the spectral region of light absorption of oxyhemoglobin and / or deoxyhemoglobin. For example, the material removal device 501 can include a thulium fiber laser capable of generating a laser beam with a wavelength of 1908 nm or 1940 nm. The material removal device 501 can include a thulium:yttrium-aluminum-garnet (YAG) laser capable of generating a laser beam with a wavelength of 2010 nm. The material removal device 501 can be a holmium:YAG laser capable of generating a laser beam with a wavelength of 2120 nm. The material removal device 501 may include an Erbium:YAG laser capable of producing a laser beam at a wavelength of 2940 nm. Other wavelengths within these ranges may also be used.

[0023] Additionally, the material removal device 501 may include a neodymium: (YAG) (Nd:YAG) laser capable of generating a laser beam at a wavelength of 1064 nm. In general, it may be advantageous to deliver a laser beam that has sufficient light absorption in blood and saline because such a laser beam may have reduced effects on surrounding tissue. This may help reduce or eliminate damage to different materials near the target site. The laser may provide light having an output power that is within a suitable range of output power, such as, for example, between 20 watts and 120 watts. The optical fiber 204 may include a multimode fiber or a single mode fiber.

[0024] The visualization system may include an image acquisition device 208 that may be located on a circuit board or other substrate 200 that may mechanically support and electrically power the image acquisition device 208. The image acquisition device 208 may have an imaging sensor, such as a camera, and may capture a video image or one or more still images of the illuminated material at the target. The video image may be real-time or quasi-real-time with a relatively low latency for processing, such that the practitioner may observe the material at the target site or surrounding tissue as the practitioner manipulates the body 106 to control the endoscope 102. The image acquisition device 208 may have a lens and a multi-pixel photodetector sensor, such as a focal plane array (FPA), that may be located at the focal plane of the lens. The sensor may include a color sensor, such as an RGB sensor, that provides intensity values ​​for red, green, and blue light at each pixel in the video image. The circuit board may generate a digital video signal that represents the captured video image of the illuminated material at the target site. The digital video signal may have a video refresh rate of 10 Hz, 20 Hz, 24 Hz, 25 Hz, 30 Hz, 40 Hz, 50 Hz, 60 Hz, or another suitable video refresh rate. In another embodiment, the image capture device 208 may be a Spectroscopic Charge Coupled Device (CCD) camera or a complementary metal-oxide-semiconductor (CMOS) camera.

[0025] In another example, the image acquisition device 208 can acquire a spectrum emitted from the target site and provide this spectrum to a feedback analyzer 121 of the platform 104, such as via an optical path 209. The optical path 209 can have a multimode or single mode optical fiber, or an optical fiber bundle. As described further below, the feedback analyzer 121 can be configured to determine the spectrum of the fluorescent signal or other response signal. Additionally, as described further below, the feedback analyzer 121 can be configured to identify a characteristic of the target site using the identified spectrum.

[0026] The endoscope 102 may further include an irrigation lumen 210 and an aspiration lumen 212 (each of which may be the same as or different from the working channel). The irrigation lumen 210 may provide an irrigant to the target site during the procedure. Additionally, the aspiration lumen 212 may remove irrigant and waste materials from the target site. The endoscope 102 may optionally include a tube, chamber, additional working channel, or other passageway 214 within the body 106 of the endoscope 102. The passageway 214 may be used by the practitioner to deploy any type of separate tool or instrument, such as a lithotriptor, stone retrieval basket, or another suitable tool or instrument.

[0027] 1, the endoscope 102 can have a laser control device 122, such as a laser control device that can be located on the graspable proximal portion 108. Alternatively, the laser control device 122 can be located remotely from the endoscope 102. The laser control device 122 can switch the state of the laser beam between an operational state ("on" state) and a non-operational state ("off" state). For example, the laser control device 122 can send wired and / or wireless laser control signals to a laser located outside the endoscope 102. The laser control signal can turn the laser on or off. In some implementations, the practitioner can use the laser control device 122 to adjust one or more settings of the laser, such as output power, pulse width, pulse shape, and / or pulse frequency.

[0028] During a procedure, the laser control device 122 can be operated to allow the practitioner to activate the laser for a period of time, such as 1 minute, 2 minutes, 3 minutes, 4 minutes, or any suitable length of time. During the period of laser operation, the practitioner can manipulate the body 106 of the endoscope 102 to move the delivered laser beam over the surface of the material at the target site. The laser power level and exposure time can be such that it allows the practitioner to safely manually turn the laser power on and off without the need for a mechanized or automatic exposure mechanism. The laser power can also be low enough to allow accidental exposure of surrounding tissue to be avoided from affecting the surrounding tissue. Additionally, the endoscope 102 can have or be coupled to a flash controller 124, which can be used to control the flow rate of irrigation agent through the irrigation lumen 210 and the suction power through the suction lumen 212.

[0029] 3 shows certain structural components of the feedback analyzer 121. The feedback analyzer 121 may have a photodetector 300 configured to detect an optical signal (e.g., a fluorescent signal, a reflected signal, or other response signal) from the target structure and analyze the received signal to determine a characteristic of the target. This signal processing and analysis may include analysis of, for example, the fluorescent intensity, the reflected intensity, or other response signal intensity, the fluorescent excitation spectrum, the fluorescent emission spectrum, the reflected spectrum, or other response signal spectrum, the fluorescent decay time, the reflected decay time, or other response signal decay time, or other characteristics associated with the detected fluorescent signal, reflected signal, or other response signal. For example, the feedback analyzer 121 may generate one or more spectroscopic properties from the detected signal. The spectroscopic properties may include one or more fluorescent signal characteristics or other response signal characteristics, and additionally or alternatively, one or more other response signal characteristics, such as a reflectance, a reflectance spectrum, or an absorption index. The photodetector 300 may comprise, among others, a spectroscopic sensor, such as a Fourier Transform Infrared (FTIR) spectrometer, a Raman spectrometer, a UV-VIS spectrometer, a UV-VIS-IR spectrometer, or a fluorescence spectrometer. Furthermore, optical sensors are suitable, such as sensors based on CMOS technology, CCD technology, for converting photons into electrical signals using photodiodes. The photodetector may be an individual photodiode, or may be an array of photodiodes, such as those used in CMOS or CCD imagers for digital cameras. Both of these types of devices provide electrical signals corresponding to the intensity of optical signals at specific wavelengths, and are suitable for performing spectroscopy. In addition, any type of spectrometer or spectrophotometer capable of collecting light intensity versus wavelength may be used. The photodetector 300 may correspond to a spectroscopic method or technique.For example, UV-VIS spectroscopy can be used to gather information from fluorescent or reflected light or other response light from a target or target site, which may be similar to information obtained from the eye or from a color image made by a high-resolution camera, but is more quantitative and objective. For example, spectroscopy can provide information about a material based on reflected light from a target. This is because the reflection and absorption of light can be determined by its chemical composition and surface properties. Information about both the surface properties and bulk properties of a sample can be obtained using this technique. Reflectance spectroscopy can be used to identify the composition of soft or hard tissues. FTIR spectroscopy can be used for rapid material analysis, has relatively good spatial resolution, and can give information about the chemical composition of a material. Raman spectroscopy can be used to identify the composition of hard and soft tissues. As a high spatial resolution technique, Raman spectroscopy is also useful for determining the spatial distribution of the composition of a material within a target.

[0030] Additionally, the photodetector 300 may be used with fluorescence spectroscopy. Fluorescence spectroscopy is a type of electromagnetic spectroscopy that analyzes fluorescence from a sample. Fluorescence spectroscopy may involve using a beam of illumination light, such as ultraviolet light, to excite material components at a target site to emit fluorescent response light, typically within the visible or IR range of the material composition. Fluorescence spectroscopy may be applied to the analysis of some organic components, such as to help distinguish hard and soft tissues. The photodetector 300 may have two or more types of spectrometers or imaging cameras, such as those that allow a wider range of capabilities to sense and detect various structures (e.g., charred tissue, non-charred tissue, or vasculature). Additionally, an imaging sensor may utilize one or more imaging capabilities of the endoscope 102 that are available for use during a therapeutic or diagnostic procedure. For example, the endoscope 102 may be used to visualize anatomical structures during a therapeutic procedure (e.g., laser ablation of tumors or kidney stones). In such cases, the endoscopic imaging capabilities of the endoscope 102 may be used or augmented by the optical detector 300. For example, the endoscope 102 may provide narrow band imaging suitable for improving visualization of one or more anatomical structures (e.g., lesions, tumors, vasculature, stones, etc.). The optical detector 300 may be combined with endoscopic imaging (white light and / or narrow band imaging) to help detect one or more tissue properties, such as the level of carbonization, and this information may be used to precisely control the delivery of a therapeutic therapy. For example, the optical detector 300 may be operably coupled to the optical path 209. Thus, an optical signal, such as a fluorescent signal or other response signal received at the optical path 209, may be provided to the optical detector 300.

[0031] The feedback analyzer 121 may have an imaging sensor 302 along with one or more of a target detector 304 or a target classifier 306. The target detector 304 may be configured to identify the target structure as one of a plurality of structural segments, such as may include using one or more fluorescent properties of the detected fluorescent or other response signal and / or one or more spectroscopic properties, such as those generated by the light detector 300, as described above. Additionally, the target detector 304 may be configured to identify the target structure as one of a plurality of structural segments in combination with the imaging properties detected by the imaging sensor 302. For example, the target detector 304 may use one or more fluorescent properties and / or other response signal spectroscopic properties to identify the target characteristics, such as to help characterize the target structure as a stone structure segment or as an anatomical structure segment. Examples of stone structures may include stones or crushed stones in various stone-forming regions, such as the urinary system, the gallbladder, the nasal cavity, the gastrointestinal tract, the stomach, or the tonsils. Examples of anatomical structures may include soft tissues (eg, muscles, tendons, ligaments, blood vessels, fascia, skin, fat, and fibrous tissues), hard tissues such as bone, and connective tissues such as cartilage, among others.

[0032] The feedback analyzer 121 can generate a response signal spectrum, such as a reflectance spectrum using the received reflected signal, and can extract one or more spectral features from the reflectance spectrum. The response signal spectrum can include reflectance intensity across multiple wavelengths. The reflectance can be determined as a function of incident electromagnetic power reflecting at a material interface. The reflectance can represent the effectiveness of a material surface at reflecting electromagnetic radiation. In addition to reflectance, the response signal spectrum can also represent illumination energy absorbed at the body site and re-emitted at the fluorescent response signal wavelength, including a short time after the light source no longer illuminates the body site. The reflectance spectrum can be formatted as a data array or as a graphical representation, such as a spectral reflectance curve. For example, the reflectance spectrum can represent reflectance across wavelengths in a range of about 400 nm to about 1000 nm.

[0033] The articulated controller 116, laser controller 122, flash controller 124, feedback analyzer 121, and / or target detector 304 described herein may be implemented as a single controller or individual controllers. Additionally, two or more of these may be implemented as a single controller while the rest are implemented as individual controllers. The controllers used herein may be implemented as hardware, software, or a combination of the two. The software may be written in any of a number of high-level languages, such as FORTRAN, PASCAL, JAVA, C, C++, C#, BASIC, various scripting languages, and / or HTML. Additionally, the software may be implemented as assembly language for a microprocessor resident on the target computer. The software may be embodied as an article of manufacture, including, but not limited to, a floppy disk, a jump drive, a hard disk, an optical disk, a magnetic tape, a PROM, an EPROM, an EEPROM, a field programmable gate array, or a CD-ROM. The hardware circuitry may be implemented using, for example, one or more FPGA, CPLD, or ASIC processors.

[0034] FIG. 4 illustrates an example of a portion of a method 400 for determining a material characteristic of a target site. In operation 402, the target site may be illuminated with a light source. The light source may be activated and deactivated periodically or randomly, such as to generate pulsed illumination. For example, in operation 402, the light source may be activated to illuminate the target (i.e., the light source is in an "on" state). To further illustrate an example related to the method 400, referred to herein as a "first example," reference is now made to FIG. 5, in operation 402, the endoscope 102 may be controlled to illuminate the internal target site 500 with pulsed light 502. The light source 202 may provide white light from an LED or other broadband light to the internal target site 500 in operation 402. In the first example, broadband light or white light may be used. The white light may include all wavelengths of light in the visible spectrum at equal intensity. Thus, the white light may include wavelengths that can excite fluorophores in the internal target site 500. In a first example, a surface 504 of an internal target site 500 is illuminated with pulsed light 502. More specifically, the internal target site surface 504 absorbs energy, such as photons, that causes excitation, such as excitation of fluorophores at or beneath the internal target site surface 504.

[0035] In FIG. 4 , the light source 202 may be switched at 403 from an “on” state in which the LED emits light to an “off” state in which the LED does not emit light. During this time (i.e., when the pulsed light source is in the “off” state), a fluorescent response signal emitted from the target site is detected by the photodetector 300 of the feedback analyzer 121 in response to the illumination at operation 404. Alternatively, a reflected response signal from the target site may be detected by the photodetector 300 at operation 404. In either embodiment, because the pulsed light source is in the “off” state, the fluorescent or reflected or other response signal from the target need not be obscured or saturated by the wavelength of the illumination energy that activates the target site. This may help enable more accurate determination of the target characteristics of the target site based on the detected fluorescent, reflected, or other response signals.

[0036] The material at the target site may contain fluorophores that can be excited by a particular wavelength of light emitted by the light source. When the fluorophores are excited, they may emit light for a short period of time, as shown with reference to FIG. 6. Specifically, an excitation pulse EP, such as a pulsed broadband light or white light, is directed toward the material containing the fluorophores, and the energy absorbed by the material containing the fluorophores decays over a time T, where the decay time is proportional to the intensity I associated with the light used to illuminate the material with the fluorophores, as shown with the fluorescence F. The fluorescence F may be used to determine the fluorescence intensity and the fluorescence excitation spectrum. Additionally, the fluorescence F may be used to determine the fluorescence emission spectrum and the fluorescence decay time. A CCD or CMOS or other photosensor may be used to detect the fluorescence F before the intensity associated with the fluorescence F decays below a point where the fluorescence F cannot be detected by the CCD or CMOS or other photosensor. In operation 404, the absorbed energy may be detected as a fluorescence response signal.

[0037] At 403, the light source 202 may be switched from an “on” state in operation 402 to an “off” state. When the light source 202 is switched to the “off” state, the method 400 may perform a first example operation 404. Specifically, at operation 404, energy absorbed by the internal target site surface 504, generally shown in FIG. 7 as energy 700, is emitted as a fluorescent response signal 702 that may correspond to a wavelength emitted from the internal target site surface 504. Thus, when the internal target site surface 504 is activated, the fluorescent signal 702 may correspond to a wavelength emitted from the activated internal target site surface 504. In the first example, the fluorescent signal 702 may be transmitted via the optical path 209, the optical fiber 204, and / or the passageway 214 to the feedback analyzer 121, such that the feedback analyzer 121 may analyze the detected fluorescent or other response signal 702.

[0038] Once the fluorescent signal is detected in operation 404, the method 400 optionally performs operation 406, in which the fluorescent properties (e.g., fluorescent intensity, fluorescent excitation spectrum, fluorescent emission spectrum, and / or fluorescent decay time) and / or a spectrum associated with the fluorescent signal are determined. The feedback analyzer 121 may be used to determine the spectrum associated with the fluorescent signal, as discussed above. Additionally or alternatively, in operation 406, a spectrum may be extracted from the reflectance signal or normalized reflectance signal of a particular stone structure at the target site. The reflectance features may include a reflectance spectrum (or a normalized reflectance spectrum) at a particular wavelength or over a particular wavelength range, statistics calculated from the reflectance spectrum (e.g., change in reflectance over two or more different wavelengths, or rate of change in reflectance over a wavelength range, etc.), or graphical features representing the shape of at least a portion of the spectral reflectance curve (e.g., slope, curvature, or arc of a curve, etc.). The stone reflectance features and tissue reflectance features may be stored in a memory circuit of the platform 104.

[0039] After determining the spectrum associated with the fluorescent, reflected, or other response signal in operation 406, a characteristic of the target site may be determined in operation 408 using the fluorescent or other response property and / or spectrum. For example, to determine a characteristic of the target site in operation 408, the target detector 304 may additionally or alternatively extract one or more reflectance features from the reflectance spectrum determined in operation 406. The target detector 304 may compare the fluorescent and / or reflectance or other response feature to a predetermined threshold or value range based on the characteristic to identify the target as a stone structure if the target fluorescent and / or reflectance property or other response feature exceeds a characteristic threshold or is within a certain value range. Additionally, the target detector 304 may identify the target as kidney tissue if the target fluorescent and / or reflectance property is below a predetermined threshold or outside a value range based on the characteristic. Using the stone fluorescence properties and / or reflectance characteristics and tissue fluorescence properties and / or reflectance characteristics obtained ex vivo and / or in vivo before the procedure, a pre-defined threshold or value range may be determined. Furthermore, the thresholds or value ranges associated with the individual characteristics of the targets may be stored in a look-up table in the platform 104. In an embodiment, the threshold may be determined as a threshold that separates the stone fluorescence properties and / or reflectance characteristics and tissue fluorescence properties and / or reflectance characteristics with a specified margin.

[0040] In operation 408, the target detector 304 can trend the fluorescent properties and / or reflectance intensities of the material at the target site over a range of wavelengths, and the material can be determined based on the trend of the fluorescent properties and / or reflectance intensities (alternatively, the "fluorescence trend" or "reflectance trend"). For example, a fluorescent trend or reflectance trend can be generated in a first range of 400 nm to 550 nm. If the fluorescent trend or reflectance trend increases monotonically within the first wavelength range, the material can be determined to be a calculus structure. If the fluorescent trend or reflectance trend does not increase monotonically within the first wavelength range, the material can be identified as kidney tissue. In another example, a fluorescent trend or reflectance trend can be generated in a second range of 650 nm to 700 nm. If the fluorescent trend or reflectance trend increases monotonically within the second wavelength range, the material can be determined to be a calculus structure. If the fluorescent trend or reflectance trend decreases monotonically within the second wavelength range, the material can be determined to be kidney tissue.

[0041] A template matching method may be used by the target detector 304 to determine that the material at the internal body site is a stone structure or an anatomical structure. The target fluorescence property and / or reflectance feature may be compared with at least one of the stone fluorescence property and reflectance feature or at least one of the material fluorescence property and reflectance feature stored in the memory 308 of the feedback analyzer 121 to determine whether a matching criterion is met. For example, the material at the internal body site may be determined to be a stone structure if a dissimilarity metric between the target fluorescence property and / or reflectance feature and the stone fluorescence property and / or reflectance feature is less than a first similarity threshold, or may be identified as kidney tissue if a dissimilarity metric between the target fluorescence property and / or reflectance feature and the tissue fluorescence property and / or reflectance feature is less than a second similarity threshold.

[0042] The target classifier 306 can use the differences in the reflectance spectra between various structure types of the same section, as described above, to classify material at the target site as one of multiple structure types of the same section, such as a specific tissue type within a specified section of an anatomical structure or a specific stone type within a specified section of a stone structure. This classification can be based on one or more of the reflectances at a particular wavelength, a statistical feature (e.g., a difference or other measure of difference) of the reflectance across two or more different wavelengths, or a graphical feature generated from a graphical display of the reflectance spectra. For example, in an example where the target site includes stones, the target classifier 306 can compare the normalized reflectance at a particular wavelength (e.g., 550 nm) or wavelength range to one or more thresholds to classify stones at the internal body site as a particular stone type based on the distinct normalized reflectance spectra among the various stone types.

[0043] One or more spectral properties may be used by the target classifier 306 to classify the determined anatomical structure as one of a plurality of tissue types. For example, the target classifier 306 may be configured to classify the determined kidney tissue as one of the tissue types at a distinct anatomical location, such as renal calyx tissue, cortical tissue, bone marrow tissue, or ureteral tissue. For example, based on distinct normalized fluorescence and / or reflectance spectra among various tissue types, the target classifier 306 may classify tissue at the internal body site as a particular tissue type based on a comparison between normalized fluorescence and / or reflectance of a particular wavelength (e.g., 480 nm) or wavelength range and one or more fluorescence and / or reflectance thresholds.

[0044] The target classifier 306 may be configured to classify the determined anatomical structure as normal or abnormal tissue (e.g., cancerous tissue). Normal and cancerous tissues may exhibit distinctly different fluorescence and / or reflectance spectra with different shapes and peak locations (i.e., wavelengths at which the fluorescence and / or reflectance spectra reach peak values ​​in a certain wavelength range). The classifier 306 may be configured to classify or determine the anatomical structure as a treatment area (e.g., a tumor or polyp intended to be removed) or as a non-treatment area (e.g., blood vessels, muscles, etc.). This classification may be based on one or more of the fluorescence and / or reflectance at a particular wavelength, statistical characteristics (e.g., difference or other difference amount) of the fluorescence and / or reflectance across two or more different wavelengths, or a graphical representation (e.g., slope) generated from a graphical representation of the fluorescence and / or reflectance spectrum. Cancerous tissue may have a different spectrum compared to non-cancerous tissue. Thus, the target classifier 306 may classify tissue based on the fluorescence spectrum, reflectance spectrum, or other illumination response spectrum.

[0045] The feedback analyzer 121 can further include a controller 310. The controller 310 can automatically control the laser 501 or other material removal device 501. This can eliminate the need for a practitioner to manually control the material removal device 501.

[0046] Returning to the first example, in operation 406, the fluorescent signal 702 detected in operation 404 is transmitted to the feedback analyzer 121, which determines that the spectrum of the target when illuminated with a light source (e.g., having a wavelength in the range of 450 nm to 500 nm) has a particular spectrum (e.g., 460 nm to 700 nm). Further, in operation 408, the feedback analyzer 121 identifies a characteristic (e.g., type, material, composition, composition profile, structure, hardness, etc.) of the target at the internal body site based on the detected fluorescent signal (e.g., spectral shape and peak location).

[0047] In operation 410, the treatment device may optionally be controlled based on the identification of the material properties in operation 408. The control signal may be used to adjust various parameter settings of the device, such as, for example, the energy emission from the device. For example, if the device has a laser system, the parameter settings may include the energy of the laser pulse, the pulse frequency, the laser power, and the pulse mode, the pulse width of the laser pulse, the pulse shape of the laser pulse, the peak power of the laser pulse, or the pulse frequency representing the number of laser pulses per unit time, etc. Here, the emission may be associated with the laser related to these parameters. Furthermore, operation 410 may be performed in real time, such that one or more control signals may be sent by the controller 310 to the device, thereby adjusting the device during an internal procedure to remove tissue or any other type of organic deposits from a target site.

[0048] For example, if the material at the target site is determined to include cancerous tissue (or, in some embodiments, a kidney stone) and the device is a laser device, the controller 310 can control the laser to emit a laser beam capable of removing the cancerous tissue (or, in some embodiments, breaking up the kidney stone). Thus, the controller 310 can control the treatment device based at least in part on the determined first characteristic. Returning to the first example, here the material removal device 501 can have a Nd:YAG laser. Additionally, as discussed above, the feedback analyzer 121 identifies the tissue at the internal body site as cancerous based on the shape of the spectrum and the peak location. Thus, in operation 410 of the first example, the controller 310 can automatically control the material removal device 501 to emit a laser beam, for example at a wavelength of 1064 nm, for the purpose of removing the cancerous tissue at the internal body target site 500, such that the material removal device 501 is controlled based at least in part on the first identified target characteristic. 8, an automatic controller 310 can send a signal 802 to a material removal device 501 to target a laser beam 800 at an internal body site 500 via an optical fiber 204. Once operation 410 is completed, the method 400 is complete, or alternatively, operations 402-410 may be performed repeatedly until a particular therapeutic effect is achieved (e.g., when the fragmentation or pulverization of the kidney stone is complete).

[0049] When the light source 202 is switched between an "on" state and an "off" state, different excitation wavelengths may be emitted during the time when the light source is in the "off" state. For example, the light source 202 or the material removal device 501 may be capable of emitting different excitation wavelengths. To further illustrate, the different excitation may have a wavelength of 370 nm, which may produce fluorescence between about 425 nm and 550 nm, as shown in FIG. 9. In FIG. 9, if neoplastic tissue is present, the spectrum will reflect this, as shown at point 900. Additionally, the spectrum may also reflect the presence of healthy tissue, as shown at point 902.

[0050] Method 400 may be performed during a first time period, where a first spectrum associated with the fluorescent signal is determined, a property of the material at the internal target site 500 is determined during the first time period, and a first control signal, such as control signal 802, is sent from controller 310 to material removal device 501, where material removal device 501 may be controlled in real time based on the decisions made during the first time period. Method 400 may be repeated during a second time period, where a second spectrum associated with the fluorescent signal is determined, a second property of the material at the internal target site 500 is determined during the second time period, and material removal device 501 is controlled in real time based on the decisions made during the second time period. In particular, controller 310 may send signal 804 (FIG. 8) based on the decisions made during the second time period, where a second property of the target may be determined during the second time period using the principles discussed herein. Furthermore, the second property may be different from the first property or may be the same as the first property. For example, a characteristic may be determined to be different than the characteristic determined during the first time period. Here, the laser may be controlled based on the determination of the characteristic during the second time period. Further, a second control signal 804 and a second adjustment after the second time period based on the second control signal 804 may be performed in real time.

[0051] The device may be controlled by making a second adjustment to the laser. The second adjustment may include adjusting one or more parameters of the laser, such as the energy of the laser pulse, the pulse frequency, the laser power, and the pulse mode. Furthermore, in some embodiments, the parameters adjusted after the first time and the parameters adjusted after the second time may be different. For example, after the first time period, the energy of the laser pulse may be adjusted, whereas after the second time period, the pulse frequency may be adjusted.

[0052] By detecting the fluorescence when the broadband light source or the white light source is in the "off" state after illuminating the internal target site in the "on" state, the characteristics of the internal target site can be determined. A plurality of light sources (e.g., light emitting diodes or LEDs) can be pulsed to illuminate the internal target site, and the fluorescence response signal can be measured after each pulsing of the light source. For example, each light source (e.g., LEDs) of the plurality of light sources can sequentially emit different colors at a sufficiently high rate, so that different color combinations can be perceived by the human eye as white light. In the case of three light sources, where the first light source emits red light, the second light source emits green light, and the third light source emits blue light, the combination of the red light source, the green light source, and the blue light source creates white light. Furthermore, although the colors red, green, and blue are discussed herein to create white light, any color of light can be used to determine the characteristics of the internal target site. The spectrum and characteristics of the target at the internal target site can be determined based on the fluorescence emitted in response to all light sources illuminating the internal target site, such as in a manner further described in FIG.

[0053] FIG. 10 shows an example of a method 1000 for characterizing an internal target site using multiple LEDs, each emitting a different wavelength of light. The LEDs may be sequentially switched on and off at a sufficiently high rate so that a combination of different colors is perceived by the human eye as white light. While the current LEDs (emitting different wavelengths of light) illuminate the target site, a fluorescent signal responsive to the already activated LEDs may be detected. For example, the light source may have a red LED, a green LED, and a blue LED. The light source may sequentially emit red light, green light, blue light, red light, green light, blue light... at a sufficiently high frequency during the laser procedure. While the green LED or the blue LED is currently emitting light, a fluorescent signal responsive to the already emitted red light may be detected and analyzed. In operation 1002, the target site may be illuminated with a first pulsed light source in an "on" state of the first pulsed light source. For example, the first light source may correspond to a first color, such as red. 11 , in operation 1002, the endoscope 102 can be controlled to illuminate the internal target site 1100 with a first pulsed first color light 1102. In a second example, in operation 1002, the light source 202 can provide red light from an LED to the internal target site 1100, where the red light can correspond to the first pulsed light 1102. In a second example, the endoscope 102 can illuminate the internal target site 1100 by causing the light source to emit red light in an “on” state, such that the surface 1104 of the internal target site 1100 is illuminated with the first pulsed first color light 1102. For example, the internal target site surface 1104 can absorb photons, which can cause excitation of fluorophores at the internal target site surface 1104.

[0054] In operation 1004, the target site may be illuminated with a second pulsed light source of a second color in an "on" state of the second pulsed light source. For example, the second light source may correspond to a second color, such as green. In operation 1004, the first pulsed light source that illuminated the internal target site in operation 1002 is in an "off" state.

[0055] During operation 1004, before operation 1004, or after operation 1004, a first fluorescent signal may be emitted from the internal target site and detected when the first pulsed light source site is in an "off" state in operation 1006. The target site may include a fluorescent dye molecule that may be excited by a particular wavelength of light emitted from the light source. Here, the fluorescent dye signal emitted in response to excitation by the first pulsed light signal may be detected while the target site is illuminated with a second pulsed light source. When the fluorescent dye molecule is excited, it may emit light for a short period of time. In operation 1006, a first fluorescent light corresponding to the first pulsed light source may be detected while the internal target site 1100 is illuminated with the second pulsed light source.

[0056] Alternatively, a first reflected signal may be emitted from and detected from an internal target site when the first pulsed light source site is in an "off" state in operation 1006. Thus, when the target site is illuminated with a second pulsed light source, a reflected signal emitted in response to excitation by the first pulsed light source may be detected.

[0057] In operation 1004, the endoscope 102 may be controlled to illuminate the internal target site 1100 with a second pulsed light 1106 having a different color than the first pulsed light 1102. For example, in operation 1004, the light source 202 may be in an "on" state to provide green light from an LED to the internal target site 1100. Additionally, in operation 1004, the first pulsed light source is in an "off" state.

[0058] In a second example, when the internal target site 1100 is illuminated with a second pulsed light source while the first pulsed light source is in an "off" state, in operation 1006, energy absorbed by the internal target site surface 1104, generally shown as energy 1200 in FIG. 12, may be emitted as a first fluorescent signal 1202. In a second example, the first fluorescent signal 1202 may correspond to a wavelength emitted from the internal target site surface 1104. When the internal target site surface 1104 is illuminated with the first pulsed light 1102, the internal target site surface 1104 may be in an activated state, and a resulting first fluorescent response signal 1202 may be detected, which may correspond to a wavelength emitted from the activated internal target site surface 1104. In a second example, the first fluorescent signal 1202 may be transmitted to the feedback analyzer 121 via the optical path 209.

[0059] In operation 1008, the target site may be illuminated with a third pulsed light source, for example, in an "on" state of the third pulsed light source illuminating using blue light. In operation 1008, the second pulsed light source that illuminated the target site in operation 1004 may be in an "off" state. Similarly, in operation 1008, the first pulsed light source that illuminated the target site in operation 1002 may be in an "off" state.

[0060] During, before, or after operation 1008, in operation 1010, a second fluorescent signal may be detected emanating from the target site in response to illumination from the second pulsed light source when the second pulsed light source site is in an "off" state. A fluorescent signal may be emitted from the target site while the target site is illuminated with a third pulsed light source. In operation 1010, a second fluorescent light corresponding to the second pulsed light source of light may be detected while the internal target site 1100 is illuminated with the third pulsed light source.

[0061] Alternatively or additionally, a second reflected signal may be emitted from and detected from the internal target site when the second pulsed light source site is in an "off" state in operation 1010. Thus, when the target site is illuminated with a third pulsed light source, a reflected signal emitted in response to excitation by the second pulsed light source may be detected.

[0062] After the third pulsed light source is switched to the "off" state (and while the first pulsed light source is switched to the "on" state), in operation 1012, a third fluorescent signal may be detected emanating from the target site when the third pulsed light source site is in the "off" state. In an embodiment, a fluorescent signal is generated by excitation from the second pulsed light source. In addition to the third fluorescent signal, in operation 1012, a third reflected signal may be emitted from the internal target site and detected when the third pulsed light source site is in the "off" state.

[0063] In operation 1018, the endoscope 102 can be controlled to illuminate the internal target site 1100 (FIG. 11) with a third pulsed light 1108, such as a blue light. In operation 1008, the light source 202 can provide blue light from an LED to the internal target site 1100 in an “on” state while the first and second pulsed light sources are in an “off” state.

[0064] When the internal target site 1100 is illuminated with the third pulsed light 1108 while the first and second pulsed light sources are in the "off" state, the energy 1200 absorbed by the internal target site surface 1104 when the internal target site 1100 is illuminated with the pulsed light 1106 in operation 1010 may be emitted as a second fluorescent signal 1204 that may correspond to a wavelength emitted from the internal target site surface 1104 in response to being excited by the second pulsed light 1106. Thus, when the internal target site surface 1104 is activated, a fluorescent signal may correspond to a wavelength emitted from the activated internal target site surface 1104 in response to being illuminated by the second pulsed light 1106. In a second example, the second fluorescent signal 1204 may be transmitted to the feedback analyzer 121 via the optical path 209.

[0065] After the second fluorescent signal is detected in operation 1010, a third fluorescent signal 1206 may be detected in operation 1012. Specifically, the third fluorescent signal 1206 may correspond to a wavelength emitted from the internal target site surface 1104 in response to being excited by the second pulsed light 1106. Thus, when the internal target site surface 1104 is activated, a fluorescent signal may correspond to a wavelength emitted from the activated internal target site surface 1104 in response to being illuminated by the third pulsed light 1108. In a second example, the third fluorescent signal 1206 may be transmitted to the feedback analyzer 121 via the optical path 209.

[0066] Although the method 1000 of FIG. 10 depicts detection of the first, second, and third fluorescent signals, it may be sufficient to detect one or two of these signals to determine the characteristics of one or more targets. For example, it may be sufficient to utilize only the first fluorescent signal or to utilize a combination of the first and third fluorescent signals to determine the characteristics of the targets. After the first (and in some embodiments, the second and third) fluorescent signals are detected in operation 1012, fluorescent properties appropriately associated with the detected signals may be determined in operation 1014. For example, spectra associated with the first, second, and / or third fluorescent signals may be determined, such as using the feedback analyzer 121. Alternatively, reflectance properties or other illumination response properties associated with the detected illumination response signals may be determined in operation 1014.

[0067] After determining the fluorescence properties or spectra associated with the first, second, and / or third fluorescence signals in operation 1014, a characteristic of the target site may be identified in operation 1016 using the fluorescence properties or spectra. To identify a characteristic of the target site in operation 1016, the target detector 304 may extract one or more target fluorescence properties and / or reflectance features from the detected fluorescence signals and / or reflectance spectra determined in operation 1014. By comparing the target fluorescence properties and / or reflectance features to a property threshold and / or feature threshold or value range, if the target fluorescence properties and / or reflectance features exceed the feature threshold or are within the value range, the target detector 304 may identify the characteristic of the target site as a stone structure. If the target fluorescence properties and / or fluorescence features are below the property threshold and / or feature threshold or are outside the value range, the target detector 304 may identify the characteristic of the target site as kidney tissue. The property threshold and / or feature threshold or value range may be determined using the stone fluorescence property and / or stone reflectance feature and the tissue fluorescence property and / or tissue reflectance feature. Further, the fluorescence property and / or feature threshold or value range may be stored in a look-up table in the platform 104. The fluorescence property threshold and / or feature threshold may be determined as a threshold that separates the stone fluorescence property and / or reflectance feature and the tissue fluorescence property and / or reflectance feature with a specified margin.

[0068] In operation 1016, the target detector 304 may trend one or more of the characteristic fluorescent properties and reflectance intensities at the target site over a range of wavelengths, as previously described above, and may identify a characteristic based on one or more trends in the fluorescent properties (or "fluorescence trends") and / or the reflectance intensity trends (or "reflectance trends").

[0069] Returning to the second example, in operation 1014, the first, second, and / or third fluorescent signals 1202-1206 detected in operations 1006, 1010, 1012 may be transmitted to a feedback analyzer 121, which determines that the fluorescent properties or spectrum of the tissue at the internal body site has a spectrum of, for example, 460 nm to 700 nm when illuminated with a light source within the range of 450 nm to 500 nm. In the second example, each of the first, second, and third fluorescent signals 1202-1206 may be stored and transmitted simultaneously to the feedback analyzer 121. Further, in operation 1016, similar to the first example, in the second example, the feedback analyzer 121 identifies the tissue at the internal body site as cancerous based, for example, on the shape and peak locations of the spectrum.

[0070] After characteristics at the target site are identified in operation 1016, an apparatus, such as a treatment device, may be controlled based on the identification of the characteristics in operation 1018. In an embodiment, controlling the apparatus may include adjusting various parameters of the apparatus, such as laser pulse energy, pulse frequency, laser power, and pulse mode, if the apparatus has a laser. Additionally, operation 1018 may be performed in real time, where one or more parameters of the apparatus may be adjusted during an intra-body procedure to remove tissue, stones, or any other type of organic deposits from an intra-body site.

[0071] In an embodiment, if the tissue at the internal body site is deemed cancerous, the control device 310 can control the laser to emit a laser beam capable of removing the cancerous tissue. Returning to the second example, here the material removal device 501 is a Nd:YGA laser. Additionally, as described above, the feedback analyzer 121 identifies the tissue at the internal body site as cancerous based on the shape of the spectrum, peak location, or other properties. Thus, in operation 1016 of the second example, the automatic control device 310 automatically controls the material removal device 501 to emit a laser beam of a specific wavelength (e.g., 1064 nm) for the purpose of removing the cancerous tissue at the internal body target site 500. Upon completion of operation 1018, the method 1000 is completed. Alternatively, operations 1002-1018 may be performed repeatedly until a therapeutic effect is achieved (e.g., when the crushing or pulverization of the kidney stone is completed).

[0072] As described, the light source may be controlled to emit light of various wavelengths. One or more optical filters may be used to filter the sensed fluorescent signal, such as to enable the use of a single or common light pulse. For example, optical filtering techniques may be used to filter wavelengths associated with the second and third wavelengths, thereby enabling the transmission of fluorescent signals associated with only the first wavelength. Similarly, optical filtering techniques may be used to filter wavelengths associated with the first and third wavelengths, thereby enabling the transmission of fluorescent signals associated with only the second wavelength. In addition, optical filtering techniques may be used to filter wavelengths associated with the first and second wavelengths, thereby enabling the transmission of fluorescent signals associated with only the third wavelength. Thus, the light source may emit light of the first, second, and third wavelengths, and optical filtering techniques may be used to filter the fluorescent signals associated with each of the first, second, and third wavelengths. Furthermore, along with the spectrum-based characteristics, the spectrum may be determined based on the filtered wavelengths, as discussed above, for the purpose of controlling the treatment device. For example, hardware such as wavelength filters may be used to filter the fluorescent signals associated with each of the first, second, and third wavelengths. Additionally, the hardware device can be programmed with software that provides the hardware with functionality for filtering the fluorescent signals associated with each of the first, second, and third wavelengths.

[0073] Method 1000 may be performed during a first time period during which characteristics at internal target site 500 are determined and material removal device 501 may be controlled in real time based on the determination. Method 1000 may be repeated during a second time period during which characteristics at internal target site 500 are determined and material removal device 501 may be controlled in real time based on the determination. The determined characteristics may change between the first and second time periods. The laser may be controlled in real time based on the change or based on the identification of the characteristics during the second time period.

[0074] For example, the laser may be controlled by making a second adjustment aimed at adjusting one of the laser or laser parameters, such as the energy of the laser pulse, the pulse frequency, the laser power, and the pulse mode, etc. The parameter adjusted after the first time may be different from the parameter adjusted after the second parameter, as explained above.

[0075] Real-time control of individual laser modules based on target characteristics A system for performing a medical procedure at a target site (e.g., ablation of a target) is now described. The system may have multiple laser modules with optical emissions of various wavelengths. A controller may be configured to control activation and / or deactivation of the laser modules based on one or more characteristics of the target, etc. Fluorescence response light from the target in response to illumination by one or more of the laser modules may be used to determine characteristics of the target site. A feedback analyzer may be used to determine the spectrum of the emitted fluorescence response signal for purposes of determining characteristics of the target.

[0076] Various wavelengths emitted by different laser modules may have various penetration depths in the body and / or may ablate various types of targets at different rates. Thus, by selectively activating and / or deactivating one or more of the laser modules based on the determined characteristics of the target at the internal site, the therapeutic effect of the target at the internal site may be adjusted or optimized. Light emitted from the selectively activated laser modules may be directed toward a laser light combiner. The laser light combiner may combine light from the output of each activated laser module and may direct the combined output toward the internal target site (e.g., via an optical path). The light energy output from the combiner may be used to ablate tissue at the internal target site. Thus, a controller may control which of the laser modules should emit light based on characteristics of tissue at the internal target site, which may be obtained before or during the laser procedure. At a first time, the controller can activate a first combination of laser modules to emit light based on tissue characteristics at the internal target site at the first time (which can be before or during the laser procedure) as determined by the feedback analyzer. At a later second time, the controller can control a second combination of laser modules, which can be different from the first combination of laser modules, to emit light based on changes in the characteristics (or changed characteristics) of the target at the internal target site as can be determined by the feedback analyzer at the second time.

[0077] 13A illustrates in more detail an example of components of the platform 104. The platform 104 may include an optical component 1300 that may be optically connected to the outputs of each of the laser modules 1302-1306. For example, the optical component 1300 may include an optical combiner that may combine the light output from the laser modules 1302-1306. The platform 104 may further include a light source 202, along with a feedback analyzer 121 and a controller 310.

[0078] The laser modules 1302-1306 may be similar to the material removal device 501 discussed above, such as may include a thulium fiber laser, a YAG laser, a holmium, YAG laser, or the like. The controller 310 may control individual ones of the laser modules 1302-1306 based on, for example, the ablation depth of the target or other characteristics of the target. The controller 310 may activate combinations of the laser modules 1302-1306 and deactivate combinations of the laser modules 1302-1306 based on, for example, the ablation depth of the target or other characteristics. This may be useful in embodiments where individual ones of the laser modules 1302-1306 may ablate tissue at a target at different rates.

[0079] Each of the laser modules 1302-1306 may be operatively connected to the optical component 1300, such as via optical fibers 1324-1328, which may be similar to the optical fiber 204 discussed above. The optical component 1300 may combine the lasers output from each of the laser modules 1302-1306. The optical fibers 1314-1318 may be connected together in the optical component 1300, such that the optical component 1300 may be combined with a feedback analyzer 121, such as the platform 104 shown in FIG.

[0080] 14 illustrates an example where the optical component 1300 can include an optical assembly 1401. Here, the optical component 1300 can include a first dichroic mirror 1400 disposed in a laser output beam path 1402-1406 received from each of the laser modules 1302-1306 at an oblique angle, such as 45°, with respect to the laser output beam paths 1402-1406. Each first dichroic mirror of the first dichroic mirror 1400 can reflect light from the laser beam paths 1402-1406 emanating from each of the laser modules 1302-1306 toward or along the optical path 126, such as to form a combined laser beam 1410 via the dichroic mirror 1400. Additionally, a lens 1408 can focus the combined laser beam 1410 from the laser modules 1302-1306 toward or along the optical path 126. The combined laser beam 1410 can include any combination of the laser beams 1402-1406, such as only the laser beam 1402, only the laser beam 1404, or only the laser beam 1406. Additionally, the combined laser beam 1410 can include a combination of the laser beams 1402 and 1404, a combination of the laser beams 1402 and 1406, or a combination of the laser beams 1404 and 1406. The optical component 1300 can further include lenses 1412, 1414, 1416, 1418 that can be positioned to direct the laser beams 1402-1406 toward the first dichroic mirror 1400, or the like.

[0081] In addition, the optical component 1300 can further provide a fluorescent response signal 1418 from the internal target site to the feedback analyzer 121, similar to that described above. The fluorescent response signal 1418 can be provided to the optical component 1300 from the endoscope 102 via the optical path 126. The fluorescent signal 1418 can be focused or directed by the lens 1408 towards a second dichroic mirror 1420. The second dichroic mirror 1420 can be disposed at an oblique angle, such as 45°, with respect to the lens 1408 and / or the feedback analyzer 121 (not shown in FIG. 14 ). Here, a dichroic mirror 1420 is in the path of the fluorescent signal 1418 and can direct the fluorescent signal 1418 toward the photodetector 208 and / or feedback analyzer 121 for purposes such as determining the composition of tissue at the internal target site illuminated by the combined laser beam 1410, as described above in connection with Figures 4 and 10.

[0082] FIG. 15 illustrates an example of a portion of a method 1500 for controlling, such as in real time, a system for removing tissue from a target site. In operation 1502, initially, tissue may be removed from a target site during an ablation procedure. The tissue may include soft tissue or hard tissue, such as a kidney stone. One of the laser modules 1302-1304 or any combination thereof may be a laser source and may provide a laser beam that may be used to ablate tissue from a target site, such as tissue from cancerous tissue within an internal target site or a kidney stone at an internal target site. One of the laser modules 1302-1304 or any combination thereof may be selected by a practitioner based on the type of tissue to be removed from an internal target site.

[0083] After the first time period, in operation 1504, a first characteristic of the target site may be identified. When tissue is removed from the target site in operation 1502, the ablation depth or other characteristics of the tissue being removed may vary. For example, during the first time period, highly vascular tissue may be removed, leaving less vascular tissue to be removed. This may be advantageous by using light of different wavelengths that may be more efficient at removing different types of tissue. In addition, different wavelengths may have different penetration depths. For example, a Nd:YAG laser emitting light at a wavelength of 1064 nm may be able to efficiently remove highly vascular tissue. However, light at this wavelength may not be well suited for removing less vascular tissue. Alternatively, a UV-VIS GaN emitting semiconductor laser with an emission range of 515 nm to 520 nm or a UV-VIS InxGa emitting semiconductor laser with an emission range of 370 nm to 493 nm may be used. 1-x N can effectively remove less vascular tissue.

[0084] In operation 1506, the plurality of laser modules may be controlled by the controller 310 to emit light at a first wavelength based on the first characteristic determined in operation 1504. Thus, if the characteristic of the target site changes in operation 1504, the light output from the plurality of laser modules may be controlled in operation 1506 to cause the emitted light to be at a first wavelength, such as to more efficiently or controllably remove tissue.

[0085] In operation 1508, tissue may be removed from the target site using emitted light at a first wavelength, such as by controlling the light output from the multiple laser modules in operation 1506.

[0086] 16 illustrates a "third example" in which, in operation 1502, optical component 1300 emits a light beam 1600 toward an internal target site 1602 having a highly vascular surface. Thus, light beam 1600 has an initial wavelength of 1064 nm, as may be emitted by laser module 1302 operating alone, while laser modules 1304 and 1306 are in an off state.

[0087] FIG. 17 shows the same “third example” in which a first characteristic of the internal target site 1602 can be determined in operation 1504 by emitting pulsed light 1700 from the light source 202 toward a surface 1702 of the internal target site 1602, such as after a first time period of ablation at the internal target site 1602, similar to that described above in operation 402 and in FIG. 5 .

[0088] 18 shows the same "third example," where energy absorbed by the internal target site surface 1702 in operation 1504 causes a fluorescent response signal 1802 to be emitted from the internal target site surface. The fluorescent signal 1802 can be transmitted to the feedback analyzer 121 via the optical path 209. The feedback analyzer 121 can determine a first characteristic, such as that the tissue at the internal target site surface 1702 is less vascular, as described above in operations 406 and 408. Because the vascularity of the internal target site 1602 changes during the first time period of ablation, the laser controller 310 can adjust the light emitted from the optical component 1300 to emit a wavelength of light, such as 532 nm, when using a Nd:YAG green laser to more efficiently or more appropriately remove less vascular tissue. In operation 1506, the laser control device 310 deactivates laser module 1302 and activates laser modules 1304 and 1306, and in operation 1508, uses this changed configuration to transmit light to remove tissue from the internal target site 1602, thereby adjusting the light emitted from the optical component 1300 in real time in response to changes in tissue composition at the internal target site 1602.

[0089] Alternative lasers that may be used to remove vascular tissue are set forth below with reference to Table I.

[0090] [Table 1]

[0091] During or after removing less vascular tissue from the internal target site during a second time period in operation 1508 (which may change the characteristics of the tissue being removed, such as when more highly vascular tissue is again encountered), a second characteristic of the internal target site is identified in operation 1510 of Figure 15. The second characteristic of the tissue at the internal target site may be determined in a manner similar to that described above in operations 402-408 of Figure 4.

[0092] The multiple laser modules may be controlled in operation 1512 by activating a second combination of the multiple laser modules to emit light at a second wavelength based on the second characteristic, such as by activating and / or deactivating appropriate laser modules to generate light for more efficiently or appropriately removing tissue. Tissue may then be removed from the internal target site in operation 1514 using the emitted light at the second wavelength.

[0093] In operation 1510, a second characteristic of the internal target site 1602 may be determined by emitting pulsed light 1704 from the light source 202 toward the internal target site surface 1702, as shown in FIG. 17. The pulsed light 1704 may be emitted after a second time period during which the light beam 1604 is emitted toward the internal target site 1602, similar to that described above in operation 402 and in FIG. 5. The absorbed response may emit a fluorescent signal 1806 at an emission wavelength responsive to the illumination energy 1804. The fluorescent signal 1806 may be transmitted via the optical path 209 to the feedback analyzer 121. The feedback analyzer 121 may determine a second characteristic at the internal target site surface 1702, now having high vascularity, as discussed above in operations 406 and 408.

[0094] Because the vascularity of the internal target site 1602 changes during the second time period during which the internal target site 1602 receives the light beam 1604, the laser controller 310 adjusts the light emitted from the optical component 1300 toward the target site 1602, such as to better or more efficiently remove highly vascular tissue (e.g., during an internal procedure, or even in real time). Thus, in operation 1512, the laser controller 310 can adjust the light emitted from the optical component 1300 by activating the laser module 1302 and deactivating the laser modules 1304 and 1306. Once the laser controller 310 has activated the laser module 1302 and deactivated the laser modules 1304 and 1306, in operation 1514, tissue can be removed from the internal target site 1602 using the light beam 1606 emitted from the laser module 1302, as shown in FIG.

[0095] In operation 1516, a third characteristic of the internal target site is identified. In operation 1514, as tissue is removed from the internal target site during the third time period, the characteristics of the tissue being removed may change. During the third time period, vascular tissue having high vascularity may be removed. However, after the third time period, tissue having low vascularity is now removed because the laser beam provided to the internal target site was able to remove tissue having high vascularity. In operation 1512, after the third time period, a characteristic of the internal target site is determined. A third characteristic of the tissue at the internal target site may be determined as described above in FIG. 4 and operations 402-408.

[0096] In operation 1518, the plurality of laser modules may be controlled to emit light at a third wavelength based on the third characteristic, which may include activating a third combination of the plurality of laser modules to emit light at the third wavelength. Thus, if a determination is made in operation 1516 that the characteristic of the internal target site has changed, in operation 1518, the light output from the plurality of laser modules may be controlled to emit light at a third wavelength that may more efficiently or more appropriately remove tissue from the internal target site using emitted light at the third wavelength.

[0097] In operation 1516, a third characteristic of the internal target site 1602 may be identified by emitting pulsed light 1706 from the light source 202 toward the internal target site surface 1702, as shown in Figure 17. The pulsed light 1706 may be emitted after a third time period during which the light beam 1606 is emitted toward the internal target site 1602, similar to that described above in operation 402 and in Figure 5.

[0098] In response to the energy 1808 absorbed by the internal target site surface 1702, a fluorescent response signal 1810 may be emitted from the internal target site surface 1702 and transmitted via optical path 209 to the feedback analyzer 121. The feedback analyzer 121 may determine a third characteristic, as discussed above in operations 406 and 408, that the tissue at the internal target site surface 1702 now has low vascularity.

[0099] Because the vascularity of the internal target site 1602 changes during the third time period while the internal target site 1602 receives the light beam 1606, the laser controller 310 adjusts the light emitted from the optical component 1300 in response to the changed characteristics at the internal target site 1602, such as in real time. Here, the light emitted from the laser module 1306 may be selected to efficiently remove tissue currently at the internal target site surface 1702. Thus, the laser controller 310 may adjust the light emitted from the optical component 1300 by deactivating the laser module 1302 and the laser module 1304 and activating the laser module 1306 during operation 1518. Once the laser controller 310 activates the laser module 1306 and deactivates the laser modules 1302 and 1304, tissue may be removed from the internal target site 1602 in operation 1520 using the light beam emitted from the laser module 1306.

[0100] In Figures 15-18, the properties are related to the vascularity of the tissue, and the light emitted from the optical component 1300 is adjusted in response to the identified vascularity. The properties of the tissue are not limited to only the vascularity of the tissue. Other examples may include kidney, pancreaticobiliary, or gallbladder stone applications, where the laser modules 1302-1306 ablate kidney, pancreaticobiliary, or gallbladder stones, and the properties are related to the properties of the kidney, pancreaticobiliary, or gallbladder stone being ablated, as well as the presence of the kidney, pancreaticobiliary, or gallbladder stone, etc. Examples are further related to other intracorporeal procedures involving the use of laser modules, such as vaporizing tissue, such as during the treatment of BPH.

[0101] 19 illustrates an example of a portion of a method 1900 for controlling a system having multiple laser modules to treat a target site. In operation 1902, a signal from the target site may be analyzed, such as to determine characteristics of the target site as discussed above. The signal may correspond to a depth of the target. As detailed above, the characteristics may include the type, material, composition, composition profile, structure, or hardness of the target site, etc. With reference to FIG. 4 and method 400 in conjunction with FIG. 10 and method 1000, the target site may be analyzed and characteristics may be determined, as discussed above.

[0102] After the signal from the target site is analyzed to determine characteristics associated with the target site, at least one laser module of the plurality of laser modules may be selectively activated in order to optimize the therapeutic effect at the target site in operation 1904. The laser controller 310, the controller 310, or the feedback analyzer 121 may selectively activate a designated group of one or more laser modules.

[0103] 17 and 18 show a fourth example in which pulsed light 1700 is emitted, similar to the first example and operation 402 with FIG. 5. Energy 1800 absorbed by the internal target site surface 1702 may be emitted as a fluorescent signal 1802, as discussed above. When the fluorescent signal 1802 is transmitted to the feedback analyzer 121, in operation 1902, the feedback analyzer 121 may determine a first characteristic that the tissue at the internal target site surface 1702 has high vascularity, as discussed above in operations 406 and 408.

[0104] In response to determining that the internal target site surface 1702 has high vascularity, the laser controller 310 can control the laser module 1302 to emit a 1064 nm light beam, in operation 1904. Thus, during operation 1904, only the laser module 1302 is activated to emit light, while the laser modules 1304 and 1306 remain deactivated in an off state.

[0105] In operation 1906, the optical component can receive light emitted from at least one selectively activated laser module. FIG. 13A illustrates an example of how the optical component 1300 can receive light emitted from laser modules 1302-1306 in operation 1906. Here, if only laser module 1302 is activated and emitting light, whereas laser module 1304 and laser module 1306 are deactivated and not emitting light, then during operation 1906 the optical component 1300 will receive light only from laser module 1302. Additionally, if laser modules 1304 and 1306 are activated and emitting light, whereas laser module 1302 is deactivated and not emitting light, then during operation 1906 the optical component 1300 will receive light only from laser modules 1304 and 1306.

[0106] Optionally, the optical component may combine light received from at least one selectively activated laser module of the plurality of laser modules in operation 1908. For example, if laser modules 1304 and 1306 are activated and emitting light, whereas laser module 1302 is deactivated and not emitting light, then during operation 1908 the optical component 1300 will combine light received from laser modules 1304 and 1306. Alternatively, if only laser module 1302 is activated and emitting light, whereas laser modules 1304 and 1306 are deactivated and not emitting light, then the optical component 1300 will not perform operation 1908 because the optical component 1300 receives light only from a single light source.

[0107] After the optical component receives the light emitted from the activated laser module in operation 1906 or the optical component receives the light in operation 1908, in operation 1910, the received or coupled light is directed towards the target site.

[0108] In the fourth example, as described above, only laser module 1302 emits light, while laser modules 1304 and 1306 remain in an off state. Thus, in operation 1906, optical component 1300 receives light from laser module 1302. Because optical component 1300 receives light only from laser module 1302, operation 1908 is not performed, and instead, in operation 1910, optical component 1300 may be controlled by controller 310 to direct light from laser module 1302 toward internal target site 1602.

[0109] The method 1900 may continue to be performed. At time T1, the feedback analyzer 121 determines a characteristic of the target site during operation 1902, and the controller 310 activates and controls the laser module 1302 for treatment of the target site during operations 1906 and 1910. At time T2, the feedback analyzer 121 determines a characteristic of the same target site during operation 1902, and the controller 310 deactivates the laser module 1302 and activates the laser modules 1304 and 1306. Further, at time T2, the optical component 1300 may receive light from the laser modules 1304 and 1306 in operation 1906 and combine the received light in operation 1908. Additionally, the combined light is directed towards the target site in operation 1910. At the next times T3 to T N This can be repeated in

[0110] In addition to the signal responding to the characteristics of the target as mentioned above, the signal can respond to the depth of the target. During treatment, the light emitted from the laser module can be absorbed too highly, thus carbonizing the tissue at the target site. This can occur if the practitioner penetrates too deeply into the target site. In operation 1902, the feedback analyzer 121 can analyze the signal to determine the depth of tissue ablation within the target site. Techniques that can be used to determine the depth of the target can include absorption spectroscopy to determine an absorption coefficient within a wide wavelength range (visible infrared (VIS-IR)) that determines the depth at which a particular wavelength of light penetrates the target. Here, based on the depth, in operation 1904, the controller 310 can activate one of the laser modules 1302-1306 and, if necessary, can deactivate one of the laser modules 1302-1306 based on the analyzed depth. Additionally, operations 1906 and 1910 can be performed along with operation 1908, if necessary.

[0111] Depth information relating to which of the laser modules 1302-1306 should be activated and deactivated based on the depth of the target may be stored in memory in the controller 310. This depth information may identify a combination of the laser modules 1302-1306 to be activated and deactivated based on the depth of the target. To further illustrate, at a first depth, the combination of laser modules 1302 and 1306 should be activated while laser module 1304 should be deactivated. At a second depth, the combination of laser modules 1304 and 1306 should be activated while laser module 1302 should be deactivated. Depth information relating to which combination of the laser modules 1302-1306 should be activated and which combination of the laser modules 1302-1306 should be deactivated may be stored in memory in the controller 310 prior to the start of the procedure.

[0112] With respect to Figures 15-19 and methods 1500 and 1900, in conjunction with the third and fourth examples, through selective activation and deactivation of laser modules 1302-1306, the therapeutic effect of targets at the target site can be optimized or tailored because various ones of laser modules 1302-1306 emit different wavelengths of light that can have different penetration depths and even ablate different types of targets at different rates.

[0113] 20 shows a schematic diagram of an example computer-based clinical decision support system (CDSS) 2000 that may be configured to control multiple lasers in real time based on a determination of the changing composition of tissue at the internal site. The CDSS 2000 may have an input interface 2002 through which patient-specific spectra associated with tissue at the internal site are provided as input features to an artificial intelligence (AI) model 2004, which in conjunction with a processor 2006 outputs the composition of the tissue at the internal site. In an inference operation, the spectra associated with the tissue at the internal site may be applied to the AI ​​model to generate an output 2008 representing the composition of the tissue at the internal site, and through a user interface (UI), the composition of the tissue at the internal site is communicated to a user, such as a clinician.

[0114] The input interface 2002 can further provide the tissue composition to the AI ​​model 2004, which in conjunction with the processor 2006 outputs a combination of laser modules to be used to ablate tissue based on the tissue composition. In an inference operation, the tissue composition can be applied to the AI ​​model to generate an output representing a combination of laser modules to be used to ablate tissue having the tissue composition. In some embodiments, a UI is used to communicate the laser module combination to a user, such as a practitioner.

[0115] The input interface 2002 can have a direct data link between the CDSS 2000 and one or more medical devices, such as the endoscope 102, that generates at least a portion of the input features. The input interface 2002 can transmit spectra associated with tissue at an internal target site directly to the CDSS 2000 during a therapeutic and / or diagnostic medical procedure. The input interface can transmit tissue composition associated with an internal target site directly to the CDSS 2000 during a therapeutic and / or diagnostic medical procedure.

[0116] Additionally or alternatively, the input interface 2002 can have a user interface that facilitates interaction between a user and the CDSS 2000. By way of further illustration, the input interface 2002 can support a user interface through which a user can manually input a spectrum associated with tissue at an internal body site. Additionally or alternatively, the input interface 2002 can provide the CDSS 2000 with access to an electronic medical record from which one or more input features can be extracted. In any of these cases, the input interface 2002 is configured to collect one or more of the following input features associated with a particular patient at or before the time the CDSS 2000 is used to determine the composition of tissue at the internal body site and to provide the combination of laser modules: For example, the first through nth input features can be associated with spectra associated with tissue at the internal body site at various time intervals. By way of further illustration, the first input feature can correspond to a spectrum associated with tissue at the internal body site at a first time interval, whereas the Nth input feature can correspond to a spectrum associated with tissue at the internal body site at an Nth time interval. In another example, the first through Nth input features can be associated with tissue compositions associated with tissue at the internal site at different time intervals. By way of further example, the first input feature can correspond to a tissue composition associated with tissue at the internal site at a first time interval, while the Nth input feature can correspond to a tissue composition associated with tissue at the internal site at the Nth time interval.

[0117] Based on one or more of the above input features, the processor 2006 can perform inference operations using the AI ​​model to generate tissue composition at the internal body site and suggest combinations of laser modules. For example, the input interface 2002 can send tissue composition associated with the tissue at the internal body site to an input layer of the AI ​​model, which communicates these input features through the AI ​​model to an output layer. The AI ​​model can provide a computer system with the ability to perform tasks by making inferences based on patterns seen in the analysis of data without being explicitly programmed. The AI ​​model performs learning and construction of algorithms (e.g., machine learning algorithms) that can learn from existing data and make predictions on new data. Such algorithms operate by assembling an AI model from example training data to make a data-driven prediction or decision expressed as an output or evaluation.

[0118] Forms for machine learning (ML) may include supervised ML and unsupervised ML. Supervised ML uses prior knowledge (e.g., examples correlating inputs to outputs or outcomes) to learn relationships between inputs and outputs. The goal of supervised ML is to learn a function that best approximates the relationship between training inputs and outputs, given some training data, so that an ML model, given an input, can implement the same relationship to generate a corresponding output. Unsupervised ML is the training of an ML algorithm using information that is not classified or labeled, allowing the algorithm to act on that information without guidance. Unsupervised ML is useful for exploratory analysis because it can automatically identify structures in the data.

[0119] Some tasks for supervised ML are classification and regression problems. Classification problems, also called categorization problems, aim to classify an item into one of several category values ​​(e.g., is this object an apple or an orange?). Regression algorithms aim to quantify some items (e.g., by providing a score for the values ​​of some inputs). Some commonly used examples of supervised ML algorithms are logistic regression (LR), naive Bayes, random forest (RF), neural network (NN), deep neural network (DNN), matrix factorization, and support vector machine (SVM).

[0120] Some tasks for unsupervised ML include clustering, representation learning, and density prediction. Some examples of unsupervised ML algorithms are k-means, principal component analysis, and autoencoders.

[0121] Another variant of ML is federated learning (also known as collaborative learning), which trains algorithms across multiple distributed devices with local data without exchanging data. This approach contrasts sharply with centralized machine learning techniques that upload multiple local datasets all to one server, and even more distributed approaches that can assume equal distribution of local data samples. Federated learning allows multiple actors to assemble a common robust machine learning model without sharing data, thereby addressing important issues such as data privacy, data security, data access rights, and access rights to heterogeneous data.

[0122] In some examples, the AI ​​model may be trained continuously or periodically prior to performing an inference operation by the processor 2006. Then, during the inference operation, the patient-specific input features provided to the AI ​​model may be passed from an input layer, through one or more hidden layers, and finally to an output layer, which provides an output corresponding to the composition of tissue at the internal site. For example, when the output layer generates an output corresponding to the composition of tissue at the internal site, a system used to ablate the internal site, such as the endoscope 102, the platform 104, the laser controller 122, the laser controller 310, or the laser 501, may be adjusted based on the composition to perform the internal procedure.

[0123] During and / or following the inference operation, the composition of the tissue at the internal site may be communicated to a user via a user interface (UI) and / or automatically cause the endoscope 102, platform 104, laser control device 122, laser control device 310, or laser 501 to perform a desired action, such as ablation of the internal site.

[0124] 21 is a block diagram 2100 illustrating an example of a portion of a software architecture 2102 that may be installed on any one or more of the devices described above. The software architecture 2102 may be implemented by hardware, such as a machine 2200 having a processor 2202, memory 2230, and / or I / O components 2250. The software architecture 2102 may include a stack of layers, where each layer may provide a particular functionality. For example, the software architecture 2102 has layers, such as an operating system 2104, libraries 2106, frameworks 2108, and applications 2110. In operation, the applications 2110, according to some implementations, invoke application programming interface (API) calls 2112 through the software stack and receive messages 2114 in response to the API calls 2112.

[0125] In various implementations, the operating system 2104 can manage hardware resources and provide general services. The operating system 2104 can have a kernel 2120, services 2122, and drivers 2124. The kernel 2120 can act as an abstraction layer between the hardware and other software layers. For example, the kernel 2120 can provide memory management, processor management (e.g., scheduling), component management, networking, and security settings, among other functionalities. The services 2122 can provide other general services for the other software layers. The drivers 2124 can be responsible for controlling or interacting with the underlying hardware. For example, the drivers 2124 can include a display driver, a camera driver, a Bluetooth driver, a flash memory driver, a serial communication driver (e.g., a Universal Serial Bus (USB) driver), a Wi-Fi driver, an audio driver, and a power management driver, etc.

[0126] In some implementations, libraries 2106 provide a low-level, general infrastructure that can be utilized by applications 2110. The libraries 2106 can include a home library 2130 (e.g., a C standard library) that can provide functions such as memory allocation functions, string manipulation functions, and mathematical functions. In addition, libraries 2106 may include API libraries 2132, such as a media library (e.g., a library for supporting the rendering and manipulation of various media formats, such as Moving Picture Experts Group-4 (MPEG4), Advanced Video Coding (H.264 or AVC), Moving Picture Experts Group Layer-3 (MP3), Advanced Audio Coding (AAC), Adaptive Multi-Rate (AMR) audio codec, Joint Photographic Experts Group (JPEG or JPG), or Portable Network Graphics (PNG)), a graphics library (e.g., an OpenGL framework used to render in a two-dimensional (2D) or three-dimensional (3D) graphical context on a display), a database library (e.g., SQLite for providing various relational database functions), and a web library (e.g., WebKit for providing web browsing functionality). The libraries 2106 may further include a wide variety of other libraries 2134 to provide many other APIs to the applications 2110 .

[0127] The framework 2108, according to some implementations, provides a high-level, general infrastructure that can be utilized by the applications 2110. For example, the framework 2108 provides various graphic user interface (GUI) functions, high-level resource management functions, high-level location functions, etc. The framework 2108 can provide a wide spectrum of other APIs that can be utilized by the applications 2110, some of which may be specific to a particular operating system or platform.

[0128] The applications 2110 may include a broad classification of other applications, such as a home application 2150, a contacts application 2152, a browser application 2154, a book reader application 2156, a location application 2158, a media application 2160, a messaging application 2162, a games application 2164, and third party applications 2166. The applications 2110 may include programs that perform functions defined within the programs. A variety of programming languages ​​may be employed to create one or more of the applications 2110 that are structured in a variety of ways, such as object-oriented programming languages ​​(e.g., Objective-C, Java, or C++) or procedural programming languages ​​(e.g., C or assembly language). In particular examples, third party application 2166 (e.g., an application developed using an Android® or iOS® software development kit (SDK) by an entity other than a particular platform vendor) may be mobile software running on a mobile operating system, such as iOS, Android, Windows® Phone, or other mobile operating system. In this example, third party application 2166 may invoke API calls 2112 provided by the mobile operating system (e.g., operating system 2104) to facilitate the functionality described herein.

[0129] Certain embodiments are described herein as including logic or as including multiple components, modules, or mechanisms. A module may constitute a software module (e.g., code embodied on (1) a non-transitory machine-readable medium or (2) in a transmission signal) or a hardware-implemented module. A hardware-implemented module is a tangible unit that can perform certain operations and may be configured or arranged in a particular way. In embodiments, one or more computer systems (e.g., a stand-alone computer system, a client computer system, or a server computer system) or one or more processors may be configured by software (e.g., an application or a portion of an application) as a hardware-implemented module that operates to perform certain operations described herein.

[0130] A hardware-implemented module may be implemented mechanically or electronically. For example, a hardware-implemented module may include dedicated circuitry or logic that is permanently configured (e.g., as a special-purpose processor, such as a field programmable gate array (FPGA) or application-specific integrated circuit (ASIC)) to perform certain operations. A hardware-implemented module may also include programmable logic or circuitry (e.g., contained in a general-purpose processor or other programmable processor) that is temporarily configured by software to perform certain operations.

[0131] Thus, the term "hardware-implemented module" should be understood to encompass a tangible entity that is a physically constructed entity that is permanently configured (hardwired) or temporarily configured (e.g., programmed) to behave in a particular way and / or to perform particular operations described herein. Although examples are discussed in which the hardware-implemented modules are temporarily configured (e.g., programmed), it is not necessary that each of the hardware-implemented modules be configured or instantiated at any one instance of time. For example, if the hardware-implemented modules include a general-purpose processor that is configured using software, the general-purpose processor may be configured as different hardware-implemented modules at various times. Thus, the software may configure the processor, for example, to construct a particular hardware-implemented module at one instance of time and another hardware-implemented module at another instance of time.

[0132] A hardware-implemented module can provide information to and receive information from other hardware-implemented modules. Thus, the described hardware-implemented modules can be considered as communicatively connected. When multiple such hardware-implemented modules are present simultaneously, communication can be achieved through signal transmission (e.g., via appropriate circuits and buses) connecting the hardware-implemented modules. In examples in which multiple hardware-implemented modules are configured or instantiated at various times, communication between such hardware-implemented modules can be achieved, for example, through storage and retrieval of information in a memory structure accessed by the multiple hardware-implemented modules. For example, one hardware-implemented module can perform an operation and store the output of the operation in a memory device communicatively connected to the one hardware-implemented module. Additionally, another hardware-implemented module can access the memory device at a later time to retrieve and process the stored output. A hardware-implemented module can further initiate communication with an input device or an output device and can operate on a resource (e.g., collect information).

[0133] Various operations of the example methods described herein may be performed, at least in part, by one or more processors that are temporarily configured (e.g., by software) or permanently configured to perform the associated operations. Whether temporarily or permanently configured, the processor may constitute a processor-implemented module that operates to perform one or more operations or functions. Modules referenced herein may, in some embodiments, include processor-implemented modules.

[0134] Similarly, the methods described herein may be at least partially processor-implemented. For example, at least some of the operations of the methods may be performed by one or more processors or processor-implemented modules. Performance of a particular operation is distributed among one or more processors that reside not only within a single machine, but also deployed across multiple machines. The processors may be located at a single location (e.g., in a home environment, an office environment, or a server farm) or the processors may be distributed across multiple locations.

[0135] The one or more processors may further operate to facilitate performance of associated operations within a "cloud computing" environment or as "Software as a service (SaaS)." For example, at least some of the operations may be performed by a group of computers (as examples of machines that include a processor), which are accessible over a network (e.g., the Internet) and via one or more suitable interfaces (e.g., application program interfaces (APIs)).

[0136] A part may be implemented in digital electronic circuitry, or in computer hardware, firmware, software, or in combinations of them. A part may be implemented using a computer program product, e.g. a computer program tangibly embodied in an information carrier, e.g. in a machine-readable medium, for execution by or to control the operation of a data processing apparatus, e.g. a programmable processor, a computer, or multiple computers.

[0137] A computer program may be written in any form of programmable language, including compiled or interpreted languages, and may be deployed in any form, including as a stand-alone program or as a module, subroutine, or other unit suitable for use in a computing environment. A computer program may be deployed to be executed on one computer or on multiple computers at one site or distributed across multiple sites and interconnected by a communication network.

[0138] A computing system may include clients and servers. Clients and servers are generally remote from each other and may interact through a communications network. The relationship of client and server arises by virtue of computer programs running on the respective computers having a client-server relationship to each other. Both hardware and software architectures may be used to implement the programmable computing system. Examples of hardware (e.g., machines) and software architectures that may be deployed are described below.

[0139] FIG. 22 is a block diagram of a machine by which instructions may be executed to perform any one or more of the methodologies described herein. The machine may be any of the devices described above. The machine may operate as a standalone device or may be connected (e.g., networked) to other machines. In a networked deployment, the machine may operate in the capacity of a server machine or a client machine in a server-client network environment, or may operate as a peer machine in a peer-to-peer (or distributed) network environment. The machine may be a personal computer (PC), a tablet PC, a set-top box (STB), a personal digital assistant (PDA), a mobile phone, a web appliance, a network router, switch or bridge, or any machine capable of executing (sequentially or otherwise) instructions that specify actions to be taken by the machine. Furthermore, although only a single machine is shown, the term "machine" shall also be construed to include any collection of machines that individually or collectively execute a set (or sets) of instructions to perform any one or more of the methodologies discussed herein.

[0140] An embodiment of the computer system 2200 includes a processor 2202 (e.g., a central processing unit (CPU), a graphics processing unit (GPU), or both), a main memory 2204, and a static memory 2206, which communicate with each other via a bus 2208. The computer system 2200 may further include a video display unit 2210 (e.g., a liquid crystal display (LCD) or a cathode ray tube (CRT)). The computer system 2200 further includes an alphanumeric input device 2212 (e.g., a keyboard), a user interface (UI) navigation device (cursor control device) 2214 (e.g., a mouse), a drive unit 2216, a signal generating device 2218 (e.g., a speaker), and a network interface device 2220.

[0141] The drive unit 2216 includes a machine-readable medium 2222 on which one or more sets of instructions and data structures (e.g., software) 2224 embodying or utilized by any one or more of the methodologies or functions described herein are stored. The instructions 2224 may further reside, completely or at least partially, within the main memory 2204 and / or the processor 2202 during execution thereof by the computer system 2200, with the main memory 2204 and the processor 2202 further constituting a machine-readable medium. The instructions 2224 may further reside in the static memory 2206.

[0142] While the machine-readable medium 2222 is shown in one embodiment as being a single medium, the term "machine-readable medium" may include a single medium or multiple media (e.g., a centralized or distributed database and / or associated caches and servers) that store one or more instructions or data instructions 2224. The term "machine-readable medium" should further be interpreted as including any tangible medium that can store, encode, or retain instructions 2224 for execution by a machine, cause a machine to perform any one or more of the methodologies of the present invention, or store, encode, or retain data structures utilized by or related to the instructions 2224. Thus, the term "machine-readable medium" should be interpreted to include, but is not limited to, solid-state memories, and optical and magnetic media. Specific examples of machine-readable media include, by way of example, semiconductor memory devices such as erasable programmable read-only memory (EPROM), electrically erasable programmable read-only memory (EEPROM), and flash memory devices, magnetic disks, magneto-optical disks, such as internal hard disks and removable disks, and non-volatile memory including CD-ROM disks and DVD-ROM disks.

[0143] Additionally, the instructions 2224 may be transmitted or received over a communications network 2226 using a transmission medium. The instructions 2224 may be transmitted using a network interface device 2220 and any one of a number of well-known transmission protocols (e.g., HTTP). Examples of communications networks include a local area network ("LAN"), a wide area network ("WAN"), the Internet, a cellular network, a plain old telephone service (POTS) network, and wireless data networks (e.g., Wi-Fi and Wi-Max networks). The term "transmission medium" shall be construed to include any intangible medium capable of storing, encoding, or carrying instructions 2224 for execution by a machine, including digital or analog communications signals, or other intangible media for facilitating communication of this software.

[0144] The above detailed description includes references to the accompanying drawings, which form a part of the detailed description. The drawings show, by way of illustration, specific embodiments in which the invention may be practiced. These embodiments are also referred to herein as "examples." These embodiments may include elements in addition to those shown or described. However, the inventors also contemplate embodiments that provide only those elements shown or described. Furthermore, the inventors also contemplate embodiments that use any combination or permutation of the elements shown or described (or one or more aspects thereof) in connection with the particular embodiment (or one or more aspects thereof) or in connection with other embodiments (or one or more aspects thereof) shown or described herein.

[0145] In this document, the terms "a" or "an" are used to include one or more, as commonly used in patent documents, independent of any other examples or independent of the use of "at least one" or "one or more." In this document, the term "or" is used to mean non-exclusive, i.e., "A or B" includes "A but not B," "B but not A," and "A and B," unless otherwise specified. In this document, the terms "including" and "in which" are used as the more plain English equivalents of the respective terms "comprising" and "wherein." Furthermore, in the following claims, the terms "including" and "comprising" are intended to be open-ended, i.e., a system, device, item, configuration, systemic discourse, or process that includes elements other than those recited, when such terms appear in a claim, is deemed to be within the scope of that claim. Moreover, in the following claims, the terms "first," "second," and "third," etc. are used merely as labels and are not intended to impose numerical requirements on their objects.

[0146] The above description is intended to be illustrative and not restrictive. For example, the above-described embodiments (or one or more aspects thereof) may be used in combination with each other. Other embodiments may also be used, such as by those skilled in the art reading the above description. The Abstract is provided to comply with 37 C.FR, 1.72(b) to enable the reader to quickly ascertain the nature of the technical disclosure. Thus, the Abstract is submitted with the understanding that it will not be used to interpret or limit the scope or meaning of the claims. Also, in the above Detailed Description, various features may be grouped together to streamline the disclosure. This should not be construed as intending that an unclaimed disclosed feature is essential to any claim. Rather, the subject matter of the invention may exist without satisfying all features of a particular disclosed embodiment. Thus, the following claims are incorporated into the Detailed Description as examples, where each claim stands on its own as an individual embodiment, and it is contemplated that these embodiments may be combined with each other in various combinations or permutations. The scope of the invention should be determined with reference to the appended claims, along with the full scope of equivalents to which such claims are entitled. [Explanation of symbols]

[0147] 100 Systems 102 Endoscope 104 Imaging Platform 106 Main unit 108 Proximal part 110 Long, thin, rigid part 112 Flexible distal section 114 Distal end 116 Articulating control device 118 Electrical Port 120 Display Devices 121 Feedback Analyzer 122 Laser control device 124 Flash Controller 126 Proximal part 200 Substrates 202 Light source 204 Optical Fiber 206 Optical Lenses 208 Image Acquisition Device 209 Light path 210 cleaning lumen 212 Suction lumen 214 Other passages 300 Photodetector 302 Imaging Sensor 304 Target Detector 306 Target classifier 308 Memory 310 Control device 400 ways 500 Target site in the body 501 Material removal device 502 Pulsed Light 504 Internal target site surface 700 Energy 702 Fluorescence signal, fluorescence response signal 800 Laser Beam 802 signal 804 signal 1000 ways 1100 Internal target site 1102 First Pulsed Light 1104 Surface of internal target site 1106 Second Pulsed Light 1108 Third Pulsed Light 1200 Energy 1202 First fluorescent signal 1204 Second Fluorescence Signal 1206 Third Fluorescence Signal 1300 Optical Components 1302 Laser Module 1304 Laser Module 1306 Laser Module 1314 Optical Fiber 1316 Optical Fiber 1318 Optical Fiber 1324 Optical Fiber 1326 Optical Fiber 1328 Optical Fiber 1400 Dichroic Mirror 1401 Optical assembly 1402 Laser beam path 1404 Laser beam path 1406 Laser Beam Path 1408 Lens 1410 Combined Laser Beam Path 1412 Lens 1414 Lens 1416 Lens 1418 Fluorescence response signal 1420 Second Dichroic Mirror 1500 ways 1600 Light Beam 1602 Target site in the body 1604 Light Beam 1606 Light Beam 1700 Pulsed Light 1702 Internal target site surface 1704 Pulsed Light 1706 Pulsed Light 1802 Fluorescence response signal 1804 Lighting Energy 1806 Fluorescence Signal 1808 Energy 1810 Fluorescence response signal 1900 method 2000 CDSS 2002 Input Interface 2004 Artificial Intelligence Model 2006 Processors 2008 Output 2100 Block Diagram 2102 Software Architecture 2104 Operating System 2106 Library 2108 Framework 2110 Application 2112 Application Programming Interface Call 2120 Kernel 2122 Service 2124 Driver 2132 API Library 2134 Other Libraries 2150 Home Application 2152 Contact Application 2154 Browser Application 2156 Book Reader Application 2158 Location Application 2160 Media Applications 2162 Messaging Applications 2164 Game Applications 2166 Third Party Applications 2200 Machinery and computer systems 2202 Processor 2204 Main memory 2206 Static Memory 2208 Bus 2210 Video Display Unit 2212 Alphanumeric Input Device 2214 User interface navigation device 2216 Drive Unit 2218 Signal Generating Device 2220 Network Interface Device 2222 Machine-readable medium 2224 Instructions and Data Structures 2230 Memory 2250 I / O Components

Claims

1. a plurality of laser modules, wherein a first laser module of the plurality of laser modules is configured to emit light having a first wavelength range at an internal target site and a second laser module of the plurality of laser modules is configured to emit light having a second wavelength range at an internal target site, the second wavelength range being different from the first wavelength range; an endoscope having a proximal portion and a distal portion, the distal portion configured to be inserted into a location proximate the internal target site; A control device, Analyzing a first signal from the internal target site; a controller configured to selectively activate the first laser module to treat the internal target site based at least in part on the first signal; and At least one optical component, at least one optical component having a plurality of dichroic mirrors disposed in a path of light emitted from each of the plurality of laser modules, one of the plurality of dichroic mirrors disposed at an angle to the light emitted from each of the plurality of laser modules, each one of the plurality of dichroic mirrors configured to form a combined beam of the light emitted from each of the plurality of laser modules; Equipped with The at least one optical component comprises: receiving light emitted from the first laser module; directing the received light to the internal target site; It is configured as follows: The control device, receiving a second signal from the internal target site; Analyzing the second signal; selectively activating the second laser module for tailoring a therapeutic effect at the internal target site based at least in part on the second signal; The system further comprises:

2. The system of claim 1 , wherein the endoscope comprises a light source for emitting illumination to the internal target site, and the first signal is responsive to the illumination from the light source.

3. The at least one optical component is receiving light emitted from a plurality of said selectively activated laser modules; combining light emitted from a plurality of said selectively activated laser modules; directing the combined light to the internal target site; The system of claim 1 further configured to:

4. a detector for detecting the first signal, the at least one optical component comprising: a first reflector for merging (i) a first laser beam path between the first laser module and the internal target site, and (ii) a second laser beam path between the second laser module and the internal target site; a second reflector for redirecting the first signal from the internal target site toward the detector; The system of claim 3 , comprising:

5. The system of claim 1 , wherein the controller is further configured to deactivate the first laser module.

6. The control device, analyzing the first signal to determine a distance between the endoscope and the internal target site; selectively activating at least a second laser module of the plurality of laser modules to tailor a therapeutic effect at the internal target site based on the determined distance; The system of claim 1 further configured to:

7. The optical component comprises: receiving light emitted from the second laser module; combining the light emitted from the second laser module with the light received from the first laser module; The system of claim 6 further configured to:

8. The control device, determining a distance between the endoscope and the internal target site within the patient's body based at least in part on the first signal; Based on the determined distance between the endoscope and the internal target site, deactivating at least one laser module among at least the first laser module of the plurality of laser modules; selectively activating at least a second laser module of the plurality of laser modules to tailor a therapeutic effect at the internal target site; The system of claim 1 further configured to:

9. The control device includes: analyzing the first signal from the internal target site to determine a first depth at the internal target site; selectively activating the first laser module to treat the internal target site based at least in part on the first depth at the internal target site; analyzing the second signal to determine a second depth within the internal target site; and configured to selectively activate the second laser module to tailor a therapeutic effect at the internal target site based at least in part on the second depth of the internal target site. The system of claim 1 .

10. a plurality of laser modules, wherein a first laser module of the plurality of laser modules is configured to emit light having a first wavelength range at an internal target site and a second laser module of the plurality of laser modules is configured to emit light having a second wavelength range at an internal target site, the second wavelength range being different from the first wavelength range; an endoscope having a proximal portion and a distal portion, the distal portion configured to be inserted into a location proximate the internal target site; A control device, Analyzing a first signal from the internal target site; selectively activating a combination of laser modules of the plurality of laser modules to treat the internal target site based at least in part on analysis of the first signal. A control device configured to 1. An optical component, comprising: a plurality of dichroic mirrors disposed in a path of light emitted from each of the plurality of laser modules, one of the plurality of dichroic mirrors disposed at an angle to the light emitted from each of the plurality of laser modules, each one of the plurality of dichroic mirrors configured to form a combined beam of the light emitted from each of the plurality of laser modules; receiving light emitted from said selectively activated combination of laser modules; combining received light from the selectively activated combinations of laser modules of the plurality of laser modules; directing the combined light to the internal target site; an optical component configured to Equipped with The control device, receiving a second signal from the internal target site; Analyzing the second signal; selectively activating at least a second laser module of the plurality of laser modules to tailor a therapeutic effect at the internal target site based at least in part on analysis of the second signal; The system further comprises:

11. The control device further comprises: analyzing a second signal from the internal target site; selectively activating a second combination of laser modules of the plurality of laser modules to tailor a therapeutic effect at the internal target site based at least in part on analysis of the second signal. The system of claim 10 configured to:

12. The control device further comprises: analyzing a second signal from the internal target site; Based at least in part on an analysis of the second signal, selectively deactivating at least one laser of the selectively activated combination of laser modules of the plurality of laser modules; selectively activating at least a second laser module of the plurality of laser modules to tailor a therapeutic effect at the internal target site; The system of claim 10 configured to:

13. the signal corresponds to a distance between the endoscope and the internal target site, and the controller further comprises: Analyzing the distance between the endoscope and the internal target site; Based on the distance between the endoscope and the internal target site, deactivating the selectively activated combination of laser modules; selectively activating a second combination of laser modules of the plurality of laser modules to tailor a therapeutic effect at the internal target site; The system of claim 10 configured to:

14. a detector for detecting the first signal, the optical component comprising: a first reflector for merging (i) a first laser beam path between at least a first laser module of the plurality of laser modules and the internal target site, and (ii) a second laser beam path between at least a second laser module of the plurality of laser modules and the internal target site; a second reflector for redirecting the first signal from the internal target site toward the detector; The system of claim 10 comprising:

15. The control device includes: analyzing the first signal from the internal target site to determine a first depth at the internal target site; selectively activating the first laser module to treat the internal target site based at least in part on the first depth at the internal target site; analyzing the second signal to determine a second depth within the internal target site; and configured to selectively activate the second laser module to tailor a therapeutic effect at the internal target site based at least in part on the second depth of the internal target site. The system of claim 10.

Citation Information

Patent Citations

  • Apparatus for laser irradiation

    JP1989135368A

  • Method for eliminating abnormally multiplied cell by photochemical reaction and its device

    JP1993219938A

  • Laser beam irradiation device and laser beam irradiation method

    JP2013094348A

  • In Vivo Substance Detection by Evaluating the Optical Luminescent Response to Excitation Radiation

    JP2018516705A

  • Laser system with illumination control

    US20210038064A1